Primary Sources: Roberts, L. S., & Janovy, J. (2009). Foundations of Parasitology (9th ed.). McGraw-Hill. WHO Neglected Tropical Disease fact sheets (who.int/neglected_diseases). CDC Division of Parasitic Diseases and Malaria (DPDx, cdc.gov/dpdx).

Chapter 1: Introduction to Parasitology and the Fundamentals of Parasitism

Section 1.1: Defining Parasitism

Parasitism is not a taxonomic category but an ecological relationship — one defined by metabolic dependency, harm to the host, and intimate physical association. An organism is a parasite when it lives in or on another living organism (the host), derives its nutrients from that host, and causes the host some measurable harm in the process. This three-part definition is critical: the association must be intimate (not merely incidental contact), the parasite must derive a fitness benefit at the host’s expense (distinguishing parasitism from commensalism), and the host must suffer some cost (distinguishing parasitism from mutualism). In practice, these boundaries blur — some associations grade from commensalism to parasitism depending on host immune status, parasite burden, or environmental stress — but the conceptual framework is essential for understanding the biology of host-parasite systems.

The sheer prevalence of parasitism as a lifestyle is difficult to overstate. Contemporary estimates suggest that at least half of all described animal species are parasitic at some stage of their life cycle, and when one counts parasitic plants, parasitic fungi, bacteria that behave as parasites, and the parasitic lifestyles of viruses (which many parasitologists argue should be included), the majority of Earth’s biomass is composed of parasitic organisms. Every free-living multicellular organism is simultaneously host to multiple parasite species. A single wild wood mouse (Apodemus sylvaticus) may harbor a tapeworm, one or two nematode species, a blood protozoan, a skin mite, and a louse — all at the same time. The study of parasites is therefore not a study of unusual or exotic exceptions; it is a study of the dominant mode of animal life.

The distinction between parasitism and predation is one of degree and temporal scale rather than fundamental difference. A predator typically kills and immediately consumes its prey; a parasite exploits a living host over an extended period. The predator’s fitness is maximized by killing efficiently; the parasite’s fitness is complicated by the fact that killing the host too rapidly eliminates the resource upon which the parasite depends. This constraint has driven the evolution of parasite strategies that modulate pathogenicity — a “prudent parasite” hypothesis — though the evidence is mixed and many parasites cause severe acute disease because the evolutionary pressure on virulence is more complex than simple host-conservation logic. Parasitoids (e.g., parasitic wasps that lay eggs in insects) occupy an intermediate position: their larvae develop within and ultimately kill the host, combining features of both parasitism and predation.

Parasites are classified by their anatomical relationship to the host’s body. Ectoparasites live on the external surface — skin, hair, gills, feathers — and include ticks, mites, lice, fleas, and sea lice. Endoparasites live within the body and are further subdivided into those inhabiting body cavities or the lumen of hollow organs (intestinal nematodes, tapeworms in the gut, lung flukes) versus those inhabiting tissues or cells (blood-stage malaria parasites in red blood cells, Leishmania within macrophages, Toxoplasma in muscle and brain cells, Trichinella in muscle). The tissue location of a parasite has profound consequences for host immunity, pathogenesis, and treatment, because drugs and immune effectors that function in the bloodstream may be unable to reach organisms sheltered within cells or in immune-privileged sites like the central nervous system.

Section 1.2: Parasite Life Cycles and Host Terminology

The life cycles of parasites are among the most complex and elegant biological phenomena known. Simple life cycles involve a single host species and direct transmission; complex (indirect) life cycles involve two or more obligatory host species, with different developmental stages of the parasite occurring in each host. The elaboration of complex life cycles is an evolutionary adaptation: each host in the cycle provides a specific environmental niche (metabolic substrates, temperature, pH, cellular receptors) that is optimal for a particular developmental stage of the parasite. Additionally, predator-prey relationships between hosts are exploited — the parasite completes one developmental stage in a prey animal and the next in the predator that consumes it, passively leveraging the food web for transmission.

Transmission strategies are diverse and reflect the environments in which different parasites have evolved. Fecal-oral transmission (ingestion of infective eggs or cysts shed in feces) is the dominant route for intestinal helminths and protozoa (Ascaris, Giardia, Entamoeba, Cryptosporidium); it is driven by inadequate sanitation. Skin-penetrating larvae (hookworms, Strongyloides, schistosome cercariae) enter through intact or abraded skin during environmental contact. Vector-borne transmission by blood-feeding arthropods is the mechanism for malaria, Chagas disease, leishmaniasis, lymphatic filariasis, sleeping sickness, and many others; in these systems the arthropod is not merely a syringe but a biologically essential participant in the parasite’s development. Consumption of raw or undercooked animal products transmits Taenia cysticerci (in pork and beef), Trichinella (in pork and wild game), liver flukes (in fish and watercress), and Toxoplasma (in undercooked meat). Vertical (transplacental or transmammary) transmission occurs for Toxoplasma and some nematodes. Sexual transmission is the route for Trichomonas vaginalis.

The concept of the basic reproduction number (R₀) — the average number of new infections produced by a single infected individual in a fully susceptible population — applies to parasites as it does to other infectious agents, but requires modification for organisms with complex life cycles and clonal amplification within hosts. For macroparasites (helminths), the equivalent concept is the basic reproductive rate, which accounts for the aggregated distribution of parasites among hosts (most parasites are in a minority of hosts), the density-dependent regulation of parasite fecundity, and the requirement for larvae to find and infect specific host species. Understanding these population-level parameters is essential for designing effective control interventions.

Section 1.3: Parasite Diversity Across the Tree of Life

Parasitism has evolved independently in multiple branches of the tree of life, and the parasites of medical and veterinary importance span an enormous phylogenetic range. Understanding this diversity helps explain why no single drug or approach works across all parasites, and why the evolutionary biology of each group must be understood in its own terms.

The medically important eukaryotic parasites fall into several major groups. The Platyhelminthes (flatworms) include the trematodes (flukes: Schistosoma, Fasciola, Clonorchis, Paragonimus) and cestodes (tapeworms: Taenia, Echinococcus, Diphyllobothrium). The Nematoda (roundworms) include the soil-transmitted helminths (Ascaris, Trichuris, hookworms), filarial worms (Wuchereria, Onchocerca, Loa loa, Dracunculus), and tissue nematodes (Trichinella, Toxocara). The Arthropoda include ectoparasitic insects (lice, fleas, myiasis flies), arachnids (ticks, mites), and the immense diversity of arthropod disease vectors. The single-celled eukaryotes (protists) contribute the Kinetoplastida (Trypanosoma, Leishmania), Metamonada (Giardia, Trichomonas), Apicomplexa (Plasmodium, Toxoplasma, Cryptosporidium, Babesia), and Amoebozoa (Entamoeba, Naegleria).

The evolutionary origins of parasitism within each group are distinct. In the Platyhelminthes, parasitism evolved in a lineage that was already associated with aquatic invertebrates; the ancestral trematode was probably a parasite of molluscs, and the complex life cycle involving snails as intermediate hosts reflects this ancestral association. The filarial nematodes evolved from free-living soil nematodes via a series of transitions to animal-associated (phoretic), then parasitic, then obligate parasitic relationships. The apicomplexan parasites represent a particularly striking case: the ancestral apicomplexan appears to have been a predatory or phagotrophic flagellate, and the transition to intracellular parasitism involved the co-option of the machinery for membrane invasion (the apical complex) into a tool for entering host cells. Understanding these evolutionary transitions is not merely academic: they reveal the selective pressures that shape parasite biology and may identify ancestral features that could serve as drug targets.

Chapter 2: Platyhelminthes — Trematodes (Flukes)

Section 2.1: General Trematode Biology and Life Cycle Architecture

The trematodes (class Trematoda, phylum Platyhelminthes) are endoparasitic flatworms characterized by a complex life cycle obligatorily involving a molluscan first intermediate host and typically (in the digenean trematodes) one or more additional hosts. Adult trematodes are dorsoventrally flattened, generally leaf-shaped organisms ranging from 1 mm to 7 cm in length, depending on the species. They are covered by a syncytial tegument — a living, metabolically active outer layer that is not simply a cuticle but a complex absorptive and secretory surface. The tegument protects the trematode from host enzymes and immune effectors, mediates nutrient uptake, and releases immunomodulatory molecules. The digestive system consists of an oral sucker (surrounding the mouth), a muscular pharynx, an esophagus, and bifurcated intestinal caeca — there is no anus, and undigested material is regurgitated through the mouth. The acetabulum (ventral sucker) is a powerful attachment organ but plays no digestive role.

The asexual amplification that occurs within the snail is a defining feature of trematode biology. A single miracidium may ultimately give rise to tens of thousands of cercariae through the succession of sporocyst and redia generations. This amplification compensates for the extremely low probability of any single cercaria successfully reaching and infecting the definitive host. The snail intermediate host is not merely a passive vehicle: it must be the correct species (often the parasite is highly host-specific at this stage), and the parasite manipulates snail physiology — causing infected snails to produce fewer eggs, altering their behavior, and suppressing their immune system — in ways that benefit parasite development and cercariae production.

Section 2.2: Schistosoma — Biology, Pathogenesis, and Global Burden

The schistosomes (blood flukes) are the most important trematode parasites of humans, causing schistosomiasis in approximately 240 million people and responsible for significant chronic morbidity and mortality in sub-Saharan Africa, Southeast Asia, and South America. Three species dominate human disease: Schistosoma mansoni (intestinal/hepatic schistosomiasis, Africa and South America), S. haematobium (urogenital schistosomiasis, Africa and Middle East), and S. japonicum (intestinal/hepatic, Asia). Several features of schistosome biology distinguish them from other trematodes and explain their enormous success as parasites.

Unlike other trematodes, adult schistosomes are dioecious (separate sexes). The male is broad and flat, with its lateral edges folded to create a gynecophoric canal — a groove that holds the slender, cylindrical female in intimate contact throughout adult life. The female resides within the gynecophoric canal of the male and is entirely dependent on the male for nutrients and physical support. This permanent sexual pairing is associated with continuous egg production; a single female S. mansoni produces approximately 300 eggs per day, S. japonicum produces 3,000 eggs per day. Adults inhabit the venous portal system: S. mansoni and S. japonicum are found in mesenteric venules (veins draining the intestine), while S. haematobium favors vesical venules (veins of the bladder). The anatomical location of the adults determines the disease manifestation.

Cercarial penetration is the route of human infection. Infective fork-tailed cercariae are released from freshwater snails (Biomphalaria spp. for S. mansoni, Bulinus spp. for S. haematobium, Oncomelania spp. for S. japonicum) and actively swim in water, attracted to skin by chemical and thermal gradients. On contact with human skin, cercariae attach with their oral sucker, shed their bifurcated tail, and penetrate the epidermis using mechanical boring movements assisted by secretion of proteolytic enzymes (particularly elastases and cercariopain) that digest skin proteins. Penetration is completed within minutes to an hour. The cercariae transform into schistosomulae within the skin — shedding their glycocalyx, acquiring a new double bilayer tegumental membrane, and beginning to express host-mimicking surface molecules (including host blood group antigens and MHC Class I molecules). This surface transformation is a critical immune evasion step, making the schistosomulae invisible to many host immune effectors. Schistosomulae migrate through the dermis, enter the venous or lymphatic circulation, travel to the pulmonary capillaries, cross into the pulmonary veins, enter the systemic circulation, pass through the hepatic portal system, mature sexually in the liver, and then migrate to their final venous location (mesenteric or vesical plexuses) as adult worm pairs — a journey taking approximately 4–6 weeks. During this migration, the developing schistosomes consume host red blood cells and plasma proteins.

The pathogenesis of schistosomiasis is driven primarily not by adult worms but by the host’s immune response to eggs. Adult worms are remarkably well tolerated — they can survive for decades in the portal system — but eggs become trapped in host tissues (the venule walls, intestinal mucosa, bladder wall, or liver, depending on the species) and elicit a powerful granulomatous immune response. Eggs contain a developing miracidium that secretes soluble egg antigens (SEAs) through pores in the egg shell; these antigens diffuse into surrounding tissue and trigger a Th2-dominated immune response characterized by IL-4, IL-5, IL-13, eosinophilia, and IgE production. Macrophages, eosinophils, lymphocytes, and fibroblasts accumulate around each egg to form a granuloma — a protective structure that walls off the toxic egg contents but simultaneously destroys surrounding host parenchyma. The granulomatous response in the liver (around S. mansoni and S. japonicum eggs swept there by portal blood flow) causes periportal fibrosis (Symmers clay-pipestem fibrosis), portal hypertension, splenomegaly, and — in severe cases — variceal bleeding. For S. haematobium, granuloma formation in the bladder wall causes hematuria, dysuria, and — in chronically infected individuals — squamous cell carcinoma of the bladder (S. haematobium is classified as a Group 1 carcinogen by IARC).

Acute schistosomiasis (Katayama fever) occurs in primary infections, 4–8 weeks after cercarial penetration. It represents a serum sickness-like immune complex disease caused by the formation of antigen-antibody complexes as the immune system mounts its initial response to maturing schistosomes and early egg deposition. Symptoms include fever, urticaria, cough, abdominal pain, hepatosplenomegaly, and eosinophilia — a clinical picture that can be confused with many other conditions and is frequently missed in returning travelers. Chronic schistosomiasis (developing after years of continued exposure and egg deposition) is characterized by the fibrotic complications described above and by the morbidity associated with anemia, malnutrition, and growth retardation in chronically infected children.

Treatment is with praziquantel (a pyrazinoisoquinoline derivative), which is effective against all Schistosoma species. Praziquantel’s mechanism of action involves disruption of calcium homeostasis in schistosome tegument and muscle — specifically, it causes a sudden influx of calcium ions and disruption of the tegumental surface, leading to muscular contraction, tegumental damage, and exposure of parasite surface antigens to the immune system. A single oral dose (40 mg/kg for S. mansoni and S. haematobium; 60 mg/kg in divided doses for S. japonicum) cures 85–90% of infections. Mass drug administration of praziquantel to school-age children in endemic areas is the cornerstone of WHO’s schistosomiasis control strategy.

Section 2.3: Fasciola hepatica — The Liver Fluke

Fasciola hepatica (sheep liver fluke) is a large (up to 30 × 13 mm), leaf-shaped trematode that primarily parasitizes the bile ducts of sheep, cattle, and other ruminants but is also an important human zoonotic parasite, with an estimated 2.4 million people infected and 180 million at risk. Unlike the schistosomes, the route of human infection is oral — through consumption of aquatic vegetation (particularly watercress) or water contaminated with metacercariae, the encysted infective stage attached to plant surfaces.

The life cycle involves freshwater snails of the genus Lymnaea as intermediate hosts. Eggs shed in the feces of an infected host hatch into free-swimming miracidia, which infect Lymnaea snails and undergo sporocyst and redia generations, ultimately producing cercariae that leave the snail, swim briefly, and encyst on aquatic vegetation as metacercariae. In the definitive host, ingested metacercariae excyst in the duodenum, stimulated by bile and pancreatic secretions. The juvenile flukes (immature parasites) penetrate the intestinal wall, traverse the peritoneal cavity, penetrate Glisson’s capsule of the liver, and migrate through the liver parenchyma (causing acute fasciolosis) before reaching the bile ducts, where they mature into adults and begin laying eggs (approximately 3,000 eggs per day) — a process taking approximately 3–4 months.

Acute fasciolosis (the migration phase) presents with fever, right upper quadrant pain, hepatomegaly, and marked eosinophilia — a syndrome that can mimic acute hepatitis or amoebic liver abscess. Imaging (ultrasound, CT) may show characteristic linear tracts in the liver parenchyma corresponding to the migratory paths of juvenile flukes. Chronic fasciolosis (the biliary phase) results from adult worms in the bile ducts producing intermittent biliary colic, cholangitis, obstructive jaundice, and anemia (from blood feeding; each worm consumes approximately 0.2 mL blood per day). Ectopic fasciolosis — migration of juveniles to the lung, skin, brain, or orbit — is an uncommon but dramatic complication. Treatment is with triclabendazole, a halogenated benzimidazole that inhibits tubulin polymerization in Fasciola (but not in most other helminths). A single oral dose (10 mg/kg) is highly effective against both immature and mature flukes, which is unique among available drugs.

Section 2.4: Clonorchis sinensis and Cholangiocarcinoma

Clonorchis sinensis (the Chinese liver fluke) and the closely related Opisthorchis viverrini and O. felineus are transmitted by the consumption of raw, fermented, or undercooked freshwater fish containing encysted metacercariae. These flukes are endemic in East and Southeast Asia, where traditional cuisines involving raw fish create conditions for sustained transmission; an estimated 35 million people are infected with Clonorchis or Opisthorchis. The life cycle involves freshwater snails as first intermediate hosts and cyprinid fish as second intermediate hosts. Adults inhabit the biliary tree, where light infections may be asymptomatic but heavy or chronic infections cause biliary obstruction, recurrent pyogenic cholangitis, and — most significantly — cholangiocarcinoma (bile duct carcinoma). IARC classifies both C. sinensis and O. viverrini as Group 1 biological carcinogens. The mechanism involves chronic epithelial irritation and hyperplasia driven by parasite secretions and egg-induced inflammation, accumulation of nitric oxide and reactive oxygen species that cause DNA damage, and impaired DNA repair in chronically inflamed biliary epithelium.

Section 2.5: Paragonimus westermani — The Lung Fluke

Paragonimus westermani and related species cause paragonimiasis, a food-borne zoonosis acquired by consuming raw or undercooked freshwater crustaceans (crabs and crayfish) containing metacercariae. The parasite is endemic in East and Southeast Asia, West Africa, and parts of Latin America. After excystment in the duodenum, juvenile flukes penetrate the gut wall, traverse the peritoneal cavity, cross the diaphragm into the pleural space, and migrate into the lung parenchyma, where they establish in fibrous cysts and mature into adults. The cyst typically contains two adult worms and opens into a small bronchiole, allowing eggs (and sometimes worm material) to be coughed up and either expectorated or swallowed and passed in feces.

The clinical presentation of pulmonary paragonimiasis — chronic cough, blood-tinged sputum, pleuritic chest pain, and cavitary lesions on chest X-ray — closely mimics pulmonary tuberculosis, and misdiagnosis is common in TB-endemic areas. The two diseases may also coexist. Extrapulmonary paragonimiasis occurs when juvenile flukes migrate aberrantly to the brain (cerebral paragonimiasis with seizures, headache, and focal neurological deficits) or subcutaneous tissues. Treatment is with praziquantel (75 mg/kg/day in three doses for 2–3 days) or triclabendazole.

Chapter 3: Platyhelminthes — Cestodes (Tapeworms)

Section 3.1: Cestode Biology and Body Plan

The cestodes (class Cestoda, phylum Platyhelminthes) are the second major parasitic class of flatworms. Adult cestodes inhabit the small intestine of vertebrate definitive hosts. Their most striking anatomical feature is the complete absence of a digestive system — they lack a mouth, gut, and anus entirely. All nutrient acquisition occurs by absorption through the tegument, which is structurally and functionally homologous to the trematode tegument. The tegument surface is expanded by a dense carpet of cytoplasmic extensions called microtriches (analogous to intestinal microvilli) that enormously increase the absorptive surface area. The tegument also mediates active transport of amino acids, sugars, and fatty acids; secretes enzymes that digest host intestinal contents to make them absorbable; and releases immunomodulatory compounds that suppress local intestinal immune responses.

Cestode life cycles invariably involve a vertebrate definitive host (harboring adults in the gut) and one or more intermediate hosts (harboring larval stages in tissues). The larval stage is the most medically significant in many infections: while adult tapeworms in the intestine may cause surprisingly mild symptoms, larval stages that develop in aberrant hosts (particularly humans serving as accidental intermediate hosts for tapeworms whose normal definitive hosts are carnivores) can cause devastating tissue disease — neurocysticercosis, hydatid disease, and alveolar echinococcosis being prime examples.

Section 3.2: Taenia solium — Pork Tapeworm and Neurocysticercosis

Taenia solium (the pork tapeworm) has a life cycle with humans as the definitive host (harboring adults) and pigs as the normal intermediate host (harboring larval cysticerci in muscle and brain), but humans can also serve as accidental intermediate hosts by ingesting T. solium eggs — a condition called cysticercosis that, when it involves the central nervous system, constitutes neurocysticercosis (NCC), the leading infectious cause of acquired epilepsy worldwide.

Adult T. solium in the human intestine can reach 2–4 meters in length. The scolex bears four suckers and a double row of hooks (roughly 22–32 hooks) on the rostellum — the characteristic “armed” tapeworm. Gravid proglottids detach from the strobila and are shed in feces; each proglottid contains approximately 30,000–50,000 eggs enclosed in the oncosphere (hexacanth embryo), surrounded by a radially striated embryophore. Proglottids of T. solium are not motile (unlike T. saginata) and are typically shed as chains of several proglottids rather than singly.

Cysticercosis occurs when humans ingest T. solium eggs — either from the feces of a tapeworm carrier through fecal contamination of food or water, or through autoinfection (in a tapeworm carrier, retrograde peristalsis can bring proglottids into the stomach, where eggs are released and hatch). After ingestion, eggs hatch in the small intestine, releasing oncospheres that penetrate the intestinal mucosa, enter the bloodstream, and disseminate to tissues throughout the body. The oncospheres develop into cysticerci — fluid-filled bladder-worms, 0.5–2 cm in diameter, with an invaginated scolex visible as a white opacity within the translucent cyst wall. Cysticerci can develop in any tissue but are most commonly found in skeletal muscle, subcutaneous tissue, the eye, and — critically — the brain and spinal cord.

The anatomy of a cysticercus consists of an outer cyst wall (derived from host connective tissue response to the parasite), a middle layer of parasite tegument, and the fluid-filled bladder containing the invaginated scolex (the protoscolex). As long as the cysticercus is alive, it suppresses the surrounding host immune response through a variety of mechanisms including release of taeniid antigen compounds that inhibit lymphocyte proliferation and complement activation. When the cysticercus degenerates (spontaneously or after drug treatment), the suppression is released, and a violent inflammatory response ensues — this is the cause of most clinical symptoms of NCC.

Neurocysticercosis produces symptoms that depend on the number, location, and viability of cysts. Seizures are the most common presentation (occurring in approximately 70–90% of symptomatic NCC patients) and reflect inflammatory irritation of cortical neurons by degenerating cysts. Intraparenchymal cysts in the cerebral cortex are the most common form; imaging (CT or MRI) reveals the characteristic appearance: viable cysts appear as small hypodense lesions with a hyperdense scolex (the “hole-with-a-dot” sign on MRI), while degenerating cysts show surrounding edema and ring enhancement with contrast (the host inflammatory response), and old calcified cysts appear as small hyperdense calcifications on CT — each stage representing a different point in the natural history of a dying cyst. Subarachnoid or ventricular NCC (racemose cysticercosis) involves cysts that have aberrantly enlarged to form grape-like clusters in the basal cisterns or ventricles, potentially causing hydrocephalus, meningitis, and cranial nerve palsies — a much more dangerous form. Treatment of NCC uses albendazole (7.5 mg/kg twice daily for 8–30 days) or praziquantel, always in conjunction with corticosteroids (dexamethasone or prednisolone) to manage the inflammatory response to dying cysts. Anticonvulsants are given for seizure control.

Section 3.3: Taenia saginata — Beef Tapeworm

Taenia saginata (the beef tapeworm) is the most common tapeworm of humans globally, particularly in areas where beef is consumed undercooked. The life cycle is analogous to that of T. solium, with cattle serving as intermediate hosts harboring cysticerci in muscle (Cysticercus bovis). Importantly, humans serve only as definitive hosts for T. saginata — the eggs do not cause cysticercosis in humans under natural conditions (in contrast to T. solium). Adult worms, which can exceed 10 meters in length, reside in the small intestine; infections are often discovered when the patient notices motile proglottids in the feces or on underwear. Individual proglottids of T. saginata are actively motile and can migrate out of the anus spontaneously. Infection is usually asymptomatic or causes mild abdominal discomfort, nausea, and weight loss. Treatment is a single oral dose of praziquantel (10 mg/kg).

Section 3.4: Echinococcus granulosus — Cystic Echinococcosis (Hydatid Disease)

Echinococcus granulosus is the smallest tapeworm of medical importance — adult worms are only 3–7 mm long and consist of a scolex, neck, and only 3–4 proglottids. Dogs and other canids are the definitive hosts; sheep, cattle, camels, and (accidentally) humans are intermediate hosts. Infection in humans follows ingestion of E. granulosus eggs shed in dog feces — from contaminated vegetation, water, soil, or direct contact with infected dogs. After hatching in the small intestine, oncospheres penetrate the intestinal wall, enter the portal circulation, and are carried to the liver (which filters most), with a smaller proportion reaching the lungs and other organs.

In the intermediate host, each oncosphere develops into a hydatid cyst — one of the most architecturally complex parasite structures known. The hydatid cyst consists of three layers: an outer pericyst (host-derived fibrous reaction, forming the “adventitial layer”), a middle ectocyst (the outer acellular laminated membrane produced by the parasite, with a characteristic laminated, striated appearance on pathology), and an inner germinal layer (endocyst) — the actual living parasite tissue. The germinal layer generates brood capsules (small vesicles protruding inward from the germinal layer), each containing multiple protoscolices (potential future tapeworm heads), all attached by stalks. Protoscolices are released into the cyst cavity as they mature; the cyst fluid contains thousands of free-floating protoscolices and brood capsule fragments, collectively called hydatid sand. Daughter cysts — secondary cysts formed either within the mother cyst or (after rupture) in new tissue locations — may develop. The cyst grows at approximately 1–3 cm per year and can reach sizes of 20 cm or more in the liver.

The clinical consequences of hydatid disease result from the mass effect of the growing cyst (compressing adjacent structures in the liver, lung, or wherever the cyst is located) and from the catastrophic consequences of cyst rupture. Rupture may occur spontaneously or from trauma; the hydatid fluid released is highly antigenic and can trigger anaphylactic shock — a life-threatening systemic allergic reaction. Simultaneously, protoscolices released at rupture can seed throughout the peritoneal or pleural cavity, each developing into a new cyst — a process called secondary echinococcosis. Treatment options include surgery (with careful attention to avoiding spillage), the PAIR procedure (Percutaneous Aspiration, Injection of a scolicidal agent such as hypertonic saline, Re-aspiration — recommended for cysts in the “active” stage), and chemotherapy with albendazole (which suppresses cyst growth and sterilizes the cyst contents, reducing risk of secondary seeding). Albendazole is thought to act by disrupting microtubule formation in the germinal layer, impairing glucose uptake.

Section 3.5: Echinococcus multilocularis — Alveolar Echinococcosis

Echinococcus multilocularis is the most dangerous cestode of humans. Unlike the well-demarcated, fluid-filled cyst of E. granulosus, E. multilocularis larvae grow as an alveolar mass — an infiltrating, multivesicular structure resembling a malignant tumor. The primary larval mass develops almost exclusively in the liver and grows by budding exogenously (outward into host tissue), sending projections into surrounding liver parenchyma, bile ducts, and blood vessels. The lesion has a characteristic sponge-like appearance on imaging, with irregular central necrosis (from ischemia as the parasite outgrows its blood supply) and no well-defined outer boundary. E. multilocularis can metastasize hematogenously or by direct extension to the lung, brain, and other organs. Without treatment, alveolar echinococcosis has a 10-year mortality of approximately 90%, making it functionally equivalent to a slow-growing malignancy. The definitive hosts are foxes and other wild canids; rodents serve as intermediate hosts; humans are accidental dead-end intermediate hosts, infected by ingesting eggs from contaminated vegetation or from handling infected animal carcasses in endemic regions (northern Europe, Central Asia, northern Japan, Canada, Alaska). Treatment requires prolonged (often lifelong) albendazole therapy and, where possible, radical surgical resection of the alveolar mass. Liver transplantation is considered for unresectable cases.

Section 3.6: Diphyllobothrium latum and Vitamin B₁₂ Deficiency

Diphyllobothrium latum (the broad fish tapeworm) is a pseudophyllidean cestode that can reach 10–15 meters in length — the longest tapeworm known to infect humans. Transmission occurs through consumption of raw, pickled, or undercooked freshwater fish (pike, perch, salmon, trout) containing plerocercoid larvae. The life cycle involves two intermediate hosts: a copepod (water flea) harboring the procercoid larva, and a fish (which ingests the copepod) harboring the plerocercoid (sparganum) larva in muscle tissue. Adults inhabit the small intestine and are generally well tolerated; most infections are asymptomatic.

The distinctive complication of heavy Diphyllobothrium infection is megaloblastic anemia due to vitamin B₁₂ (cobalamin) deficiency. The tapeworm preferentially absorbs vitamin B₁₂ in the upper small intestine, competing directly with the intrinsic factor-mediated absorption mechanism in the terminal ileum. The tapeworm takes up B₁₂ with extraordinary avidity — a single adult worm can accumulate up to 80% of a host’s daily B₁₂ intake — and the resulting deficiency, in sufficiently heavy infections over years, produces the same clinical and hematological picture as pernicious anemia: macrocytic anemia with hypersegmented neutrophils, subacute combined degeneration of the spinal cord, and glossitis. This interaction was historically important in populations in Scandinavia and the Baltic region, where consumption of raw fish was culturally common; it has largely declined with improved fish preparation practices. Treatment is praziquantel.

Section 3.7: Hymenolepis nana and Autoinfection

Hymenolepis nana (the dwarf tapeworm, 25–40 mm) is the most common tapeworm of humans globally, particularly in children in developing countries. It is unique among human tapeworms in not requiring an intermediate host for completion of its life cycle: eggs passed in the feces are immediately infective when ingested by a new host. More importantly, H. nana is capable of internal autoinfection — within the human intestine, eggs can hatch and the resulting cysticercoids develop in the intestinal villi before maturing into adults, allowing massive amplification of worm burden without external transmission. This feature means that immunocompromised individuals (particularly those with HIV/AIDS or on immunosuppressive therapy) can accumulate enormous numbers of worms, causing severe gastrointestinal disease, weight loss, and diarrhea. Light infections are often asymptomatic. Treatment is a single dose of praziquantel (25 mg/kg).

Chapter 4: Nematodes (Roundworms)

Section 4.1: Nematode Biology

The phylum Nematoda is one of the most numerically abundant and species-rich phyla on Earth. Nematodes are bilaterally symmetrical, non-segmented (pseudocoelomate) roundworms characterized by a tri-radiate pharynx, a longitudinal body musculature arranged in four quadrants, and a remarkably conserved overall body plan across species as phylogenetically divergent as Caenorhabditis elegans (the free-living model organism) and Wuchereria bancrofti (the filarial parasite). The outer surface is a multilayered cuticle of collagen-like proteins that is secreted by the underlying hypodermis and is shed (molted) four times during development, at the transitions from L1 to L2, L2 to L3, L3 to L4, and L4 to adult. The cuticle of parasitic nematodes is the primary interface with the host immune system, and its composition changes dramatically at each molting event.

The major groups of medically important nematodes can be organized by transmission route and tissue tropism. Soil-transmitted helminths (STH) — Ascaris lumbricoides, Trichuris trichiura, Ancylostoma duodenale, and Necator americanus — are transmitted via eggs or larvae in contaminated soil and inhabit the intestine. Filarial nematodes — Wuchereria bancrofti, Brugia malayi, Onchocerca volvulus, Loa loa, Dracunculus medinensis — are transmitted by blood-sucking arthropods and inhabit lymphatic vessels, subcutaneous tissues, or the body cavity. Tissue nematodes — Trichinella spiralis, Toxocara canis, T. cati — are acquired by ingestion and inhabit tissues rather than the intestinal lumen. Each group’s unique transmission ecology shapes both the disease it causes and the control strategies applicable.

Section 4.2: Ascaris lumbricoides — Löffler Syndrome and Intestinal Obstruction

Ascaris lumbricoides is the largest and most prevalent intestinal nematode of humans, infecting approximately 800 million people worldwide. Adult female worms reach 20–35 cm in length; males are smaller (15–30 cm). They are pale, pinkish-white, and cylindrical with tapered ends — immediately recognizable in the stool or vomitus. The infection is acquired by ingesting embryonated eggs from soil contaminated with human feces; eggs are highly resistant to environmental degradation and may remain viable in soil for years.

After ingestion, eggs hatch in the small intestine, releasing L2 larvae that penetrate the intestinal mucosa, enter mesenteric venules, and travel to the liver and then the lungs via the portal and systemic circulation. In the pulmonary capillaries, larvae break into the alveolar spaces, migrate up the respiratory tree (the mucociliary escalator), and are swallowed. This pulmonary migration phase — occurring approximately 10–14 days after ingestion — produces Löffler syndrome: a transient pulmonary infiltrate with marked eosinophilia, cough, wheezing, and dyspnea, caused by the immune response to larvae in the lung. Löffler syndrome is self-limiting (resolving as larvae are swallowed and re-enter the intestine) but can be severe in heavily infected individuals, particularly children. The differential diagnosis includes bacterial pneumonia, tuberculosis, and other causes of pulmonary eosinophilia.

After being swallowed, larvae mature to adults in the small intestine within 40–60 days. Adult worms are anchored in the lumen (not attached to the mucosa) by their muscular body and live for 1–2 years. Light infections are typically asymptomatic, but heavy worm burdens produce abdominal discomfort, nausea, and reduced nutrient absorption, contributing to childhood malnutrition and stunted growth in endemic areas. The most severe complication is intestinal obstruction from a bolus of worms — tangled masses of dozens or hundreds of adult worms can completely obstruct the small intestinal lumen, causing acute abdominal pain, vomiting, and (if untreated) intestinal perforation or volvulus. Bolus obstruction is most common in children and requires emergency management. Ectopic ascariasis occurs when worms wander into the bile duct, pancreatic duct, appendix, or peritoneal cavity — causing cholangitis, pancreatitis, appendicitis, or peritonitis. Treatment is with albendazole (400 mg single dose) or mebendazole (100 mg twice daily for 3 days); both work by binding to β-tubulin in nematode cells, inhibiting microtubule polymerization and disrupting glucose uptake, ultimately starving the worm.

Section 4.3: Trichuris trichiura — Whipworm Infection

Trichuris trichiura (the human whipworm) is one of the three primary soil-transmitted helminths, infecting approximately 800 million people worldwide. The adult worm has a distinctive morphology: the anterior three-fifths of the worm consists of a thin, filamentous “whip” that embeds deeply in the colonic mucosa (particularly in the cecum and ascending colon), while the posterior two-fifths forms a thicker “handle.” Females measure 35–50 mm; males are slightly smaller. Infection is acquired by ingestion of embryonated eggs from contaminated soil.

Light trichuriasis is asymptomatic. Moderate infections cause intermittent diarrhea and abdominal pain. Heavy infections (worm burdens of several hundred to a thousand or more adult worms) produce chronic colitis with persistent mucoid diarrhea, anemia (from mucosal blood feeding), and — in the most severe cases — trichuris dysentery syndrome: a bloody diarrhea with mucus, abdominal pain, and (classically in children) rectal prolapse caused by the combination of frequent straining and weakening of the rectal supporting structures by the intense mucosal inflammation produced by worms embedded in the rectal mucosa. The prolapsed mucosa may be visible at the anal verge, studded with worms that protrude from the mucosa like bristles. Chronic heavy infection also contributes to growth failure and cognitive impairment in children. Treatment is with albendazole or mebendazole (less efficacious against Trichuris than against Ascaris; a multi-day regimen improves efficacy).

Section 4.4: Hookworms — Iron Deficiency Anemia

The hookworms — Ancylostoma duodenale (Old World hookworm) and Necator americanus (New World hookworm) — together infect approximately 700 million people and constitute one of the most significant causes of iron deficiency anemia in the tropics and subtropics. Unlike Ascaris and Trichuris, hookworms are acquired predominantly through skin penetration by infective L3 larvae (filariform larvae) present in moist, warm soil — the classic route is walking barefoot on contaminated soil. A. duodenale can also be transmitted orally.

L3 larvae penetrate the skin (typically of the feet, causing a local inflammatory reaction — ground itch or cutaneous larva migrans in heavy infections), enter the venous circulation, travel to the lungs, break into alveolar spaces, are coughed up and swallowed (following the same “CATS” migration — Cutaneous penetration, Alveolar migration, Tracheal migration, Swallowing — as Ascaris larvae), and mature in the small intestine. Adult hookworms attach to the mucosa of the upper small intestine using cutting plates (Ancylostoma, which has plate-like teeth) or cutting blades (Necator). They feed by sucking a plug of intestinal mucosa into their buccal capsule, rupturing mucosal capillaries, and ingesting a mixture of mucosa, blood, and tissue fluids; anticoagulant secretions in the worm’s saliva prevent clotting at the feeding site. Each A. duodenale adult consumes approximately 0.2 mL of blood per day; each N. americanus consumes approximately 0.02 mL per day. A heavy infection of 100 Ancylostoma worms therefore consumes approximately 20 mL of blood daily — a significant drain over months and years of infection.

The clinical consequence of chronic hookworm infection at the population level is iron deficiency anemia — resulting from the chronic blood loss exceeding the capacity of a diet often already low in bioavailable iron to replace it. Iron deficiency anemia in hookworm-endemic populations contributes to fatigue, reduced work capacity, impaired cognitive development in children, and increased maternal and perinatal mortality in pregnant women (since pregnancy imposes additional iron demands). The WHO’s mass drug administration programs targeting soil-transmitted helminths use albendazole or mebendazole delivered to school-age children in endemic areas, but these drugs have lower efficacy against hookworms (particularly a single dose) than against Ascaris, and programs often require repeated treatment cycles.

Section 4.5: Strongyloides stercoralis — Hyperinfection in Immunosuppressed Hosts

Strongyloides stercoralis occupies a unique position among the soil-transmitted nematodes because of its capacity for autoinfection and for causing life-threatening hyperinfection syndrome in immunocompromised hosts. Unlike other STH, Strongyloides has a complex life cycle with both a free-living sexual generation and a parasitic parthenogenetic (all-female) generation. Parasitic females live embedded in the mucosa of the upper small intestine and lay eggs that hatch almost immediately within the intestinal mucosa; the resulting rhabditiform (L1) larvae emerge into the intestinal lumen and are excreted in feces. In the soil, L1 larvae can either develop into free-living adult male and female worms (indirect development) or develop directly into infective filariform (L3) larvae (direct development). In both pathways, L3 larvae infect a new host by skin penetration.

Autoinfection occurs when rhabditiform larvae in the intestine undergo accelerated development to filariform (infective) larvae within the host, before being excreted. These filariform larvae can then penetrate the intestinal wall or perianal skin, re-enter the circulation, migrate through the lungs, and re-establish intestinal infection without leaving the host. In immunocompetent individuals, autoinfection is kept at a low level by immune control — the infection is essentially permanent (lasting decades) but remains asymptomatic or causes mild abdominal discomfort and periodic urticarial skin reactions (larva currens — a rapidly moving, serpentine urticarial rash produced by larvae migrating in the dermis).

In immunosuppressed individuals — particularly those receiving corticosteroids (the most common precipitant), with HIV/AIDS, on immunosuppressive therapy for transplantation or autoimmune disease, or infected with HTLV-1 — the immune control of autoinfection fails. The result is hyperinfection syndrome: exponential amplification of worm burden through uncontrolled autoinfection, with larvae disseminating to the lung (causing hemorrhagic pneumonitis, acute respiratory distress syndrome), liver, brain, heart, kidneys, and other organs (disseminated strongyloidiasis). Larvae carry intestinal bacteria on their surface as they penetrate the gut wall, causing gram-negative bacteremia and septicemia. Mortality from hyperinfection syndrome is 70–90% without prompt diagnosis and treatment. The steroid-induced hyperinfection is particularly dangerous because corticosteroids mimic insect ecdysteroids, which are the larval molting hormones; this hormonal signal may trigger accelerated L1-to-L3 development within the host. Ivermectin is the treatment of choice for strongyloidiasis; albendazole is less effective. Importantly, patients from endemic regions who are to receive immunosuppressive therapy should be screened and treated for Strongyloides before immunosuppression begins.

Section 4.6: Wuchereria bancrofti — Lymphatic Filariasis

Wuchereria bancrofti is the principal cause of lymphatic filariasis (elephantiasis), affecting approximately 120 million people in tropical regions of Africa, Asia, the Pacific, and the Americas. The parasite is transmitted by mosquitoes (primarily Culex quinquefasciatus in urban environments, and various Anopheles and Aedes species in rural settings). L3 larvae deposited on the skin by the feeding mosquito penetrate the bite wound, migrate to lymphatic vessels and lymph nodes (particularly of the inguinal, pelvic, and axillary regions), and develop into adult worms over 6–12 months. Adult females (80–100 mm long) and males (40 mm) live in the lymphatics for 4–6 years, producing millions of microfilariae that circulate in the bloodstream.

Microfilaria periodicity is a fascinating biological adaptation: W. bancrofti microfilariae exhibit nocturnal periodicity — they are present in peripheral blood at night (peak concentration: 2:00–4:00 AM) but sequester in the pulmonary capillaries during the day. The mechanism involves circadian rhythms of the microfilariae that are entrained to the sleeping pattern of the host — and therefore synchronized to the biting pattern of Culex mosquitoes, which are predominantly night biters. Disruption of the host’s sleep schedule (through shift work, for example) shifts the microfilaria periodicity accordingly, demonstrating that the phenomenon is genuinely host-driven. The Pacific strain of W. bancrofti exhibits diurnal periodicity — microfilariae appear in peripheral blood during the day — in regions where the vector (a day-biting Aedes) bites during daylight hours.

Pathogenesis of lymphatic filariasis involves a complex interplay between the living worms, the host immune response, and secondary bacterial and fungal infections. Living adult worms in the lymphatics induce chronic lymphatic dilation and dysfunction; the acute inflammatory episodes (acute filarial lymphangitis and lymphadenitis) that punctuate the chronic course are caused by the death of adult worms (triggering intense inflammation) and by secondary bacterial and fungal infections that enter through skin barrier defects created by lymphedema. Over years, the combined effects of lymphatic obstruction, inflammation, and recurrent secondary infections produce the characteristic progressive tissue changes: lymphedema of the limb, thickening and hyperplasia of the skin (producing the rough, corrugated texture that gives the disease its name), and fibrous proliferation of the connective tissues. Hydrocele (lymph fluid accumulation in the scrotal sac, caused by obstruction of lymphatics draining the testis) is the most common manifestation in adult males in endemic areas and a major cause of disability.

Treatment with diethylcarbamazine (DEC) kills both microfilariae and adult worms but must be used carefully because the rapid killing of microfilariae triggers systemic inflammatory reactions (Mazzotti reaction). Ivermectin is highly effective against microfilariae and is the mainstay of mass drug administration programs; it is typically given in combination with albendazole (and DEC where Loa loa is not co-endemic, as DEC cannot be used where Loa loa is present because of the risk of encephalopathy). The Global Programme to Eliminate Lymphatic Filariasis (GPELF) has made extraordinary progress through mass drug administration, and elimination has been achieved in several countries.

Section 4.7: Onchocerca volvulus — River Blindness

Onchocerca volvulus causes onchocerciasis (river blindness), affecting approximately 20 million people primarily in sub-Saharan Africa (with smaller foci in Yemen, Brazil, and Venezuela). The vector is Simulium blackflies (family Simuliidae), which breed in fast-flowing, well-oxygenated rivers and streams — hence the disease’s geographical association with rivers and the name “river blindness.” Historically, the fertile river valleys most affected by onchocerciasis were effectively uninhabitable, with devastating consequences for agricultural economies in West Africa.

Adult O. volvulus worms (females up to 50 cm; males 3–5 cm) live in subcutaneous nodules (onchocercomata) — fibrous capsules formed by the host connective tissue around mating worm pairs. The nodules are palpable as firm, non-tender subcutaneous lumps, most commonly over bony prominences (iliac crests, greater trochanter, ribs, and in African infections the lower trunk; in Central American infections more commonly on the head). Adult females produce millions of microfilariae over their 10–15 year lifespan; microfilariae migrate actively through the skin and into the eye, where their death triggers the pathological response responsible for blindness.

Wolbachia — obligate intracellular endosymbiotic bacteria of the phylum Proteobacteria — are present in virtually all Onchocerca volvulus worms and play a central role in pathogenesis. When microfilariae die (spontaneously or after ivermectin treatment), they release Wolbachia lipopolysaccharide (LPS), which activates Toll-like receptor 4 (TLR4) on host immune cells, triggering a strong innate inflammatory response. In the skin, this reaction produces onchodermatitis (chronic inflammatory skin disease ranging from pruritic papular rash to depigmented “leopard skin” and atrophied “lizard skin” appearance). In the cornea, the inflammatory reaction to dying microfilariae causes punctate keratitis (cloudy spots), progressing to sclerosing keratitis (opacification of the entire cornea) and irreversible blindness after years of microfilarial death in the ocular tissue. In the posterior eye, microfilariae in the vitreous and retina cause chorioretinitis and optic atrophy.

Ivermectin (Mectizan) is a macrocyclic lactone that acts by opening glutamate-gated chloride channels in nematode neurons and muscle cells, causing hyperpolarization, flaccid paralysis, and death. It is highly effective against O. volvulus microfilariae (though not directly against adult worms) and also modulates the immune response in a way that reduces pathology. The Mectizan Donation Programme (MDP) — in which Merck donates ivermectin for as long as needed to combat onchocerciasis globally — is one of the most successful pharmaceutical donation programs in history. Annual or biannual mass community-directed treatment with ivermectin has dramatically reduced transmission and disease burden in the Onchocerciasis Control Programme regions. More recently, the discovery that doxycycline kills the Wolbachia endosymbionts and thereby sterilizes and ultimately kills adult worms has raised the prospect of eliminating transmission through a regimen combining ivermectin (microfilaricidal) with doxycycline (macrofilaricidal).

Section 4.8: Loa loa — The Eyeworm

Loa loa is a filarial parasite of Central and West Africa, transmitted by Chrysops deer flies (tabanid flies that are daytime biters of the forest canopy). Adult worms migrate through subcutaneous connective tissue, causing transient, migratory, non-pitting subcutaneous swellings (Calabar swellings) — particularly common on the wrists and hands — that resolve within days as the worm moves on. The worm occasionally crosses the conjunctiva of the eye, causing momentary sensation and visible movement — the origin of the name “eyeworm.” Microfilariae circulate in blood with diurnal periodicity (present during the day, matching the feeding pattern of Chrysops). Loa loa poses a critical challenge to filariasis control programs because individuals with high Loa microfilaremia treated with DEC or ivermectin can develop fatal encephalopathy — a severe and poorly understood inflammatory reaction in the CNS — limiting the safe use of these drugs in co-endemic areas. Treatment of symptomatic loiasis uses DEC or albendazole; surgical removal of the worm from the eye or from subcutaneous tracks is sometimes performed.

Section 4.9: Dracunculus medinensis — Guinea Worm

Dracunculus medinensis (the Guinea worm) is the focus of one of the most remarkable eradication campaigns in history. Once affecting 3.5 million people annually in 21 countries in Africa and Asia, Guinea worm disease has been reduced to single-digit annual case counts (fewer than 20 cases globally in recent years), primarily in Chad — a reduction achieved not by any drug or vaccine (there is no pharmacological treatment and no vaccine for dracunculiasis) but entirely through behavior change, water filtration, and intensive case-detection with containment.

Humans are infected by drinking water containing copepods (Cyclops spp.) harboring infective L3 larvae. After ingestion, larvae are released in the stomach, penetrate the stomach wall, migrate to connective tissues, and develop into adult worms over approximately one year. The female worm grows to 60–100 cm in length (the male, at 1–4 cm, is rarely seen). When ready to release larvae, the female migrates to the surface of the skin (usually the lower leg or foot), where she secretes chemical irritants that cause a burning blister. When the blister contacts water, it ruptures and the female slowly extrudes a loop of her body through which larvae are released into the water — where they infect copepods. The burning pain of the blister drives the patient into water, completing the cycle. The traditional treatment — slowly winding the worm on a stick at a few centimeters per day over 2–4 weeks (to avoid breaking the worm, which would cause severe inflammation and secondary bacterial infection) — is almost identical to ancient depictions, including possibly the Bronze Snake described in Numbers 21 and the medical caduceus symbol.

Section 4.10: Toxocara — Visceral Larva Migrans

Toxocara canis (from dogs) and T. cati (from cats) are the causative agents of toxocariasis in humans, who are accidental dead-end hosts. In dogs and cats, Toxocara undergoes normal intestinal development; in humans (infected by ingesting embryonated eggs from soil contaminated with pet feces), larvae hatch but cannot complete their development. Instead, they migrate through the liver, lungs, brain, and other organs for months, causing visceral larva migrans (VLM) — a syndrome of hepatomegaly, eosinophilia, fever, cough, and urticaria — and ocular larva migrans (OLM) — granuloma formation in the retina that can cause visual impairment or blindness, which may be misdiagnosed as retinoblastoma in children. Seroprevalence studies show that Toxocara exposure is common in many countries, including the United States, where dog and cat ownership combined with soil contamination in playgrounds creates ongoing exposure risk, particularly for children.

Section 4.11: Trichinella spiralis — The Nurse Cell

Trichinella spiralis is unique among helminths in completing its entire life cycle within a single host. Infection occurs when a host consumes meat containing encysted larvae; in the intestine, larvae excyst, penetrate the intestinal mucosa, and rapidly mature into adults. Female adults produce larvae that enter the intestinal lymphatics, disseminate through the circulation, and invade striated muscle cells — but not just any cells.

The clinical manifestations of trichinellosis depend on the worm burden. During the intestinal phase (days 1–7), mild symptoms of nausea, diarrhea, and abdominal cramps occur. During the larval migration phase (weeks 2–6), systemic inflammatory responses produce the classic triad: periorbital edema (a characteristic early sign, caused by larval invasion of masticatory muscles and local allergic edema), myalgia (from invasion of striated muscles — the diaphragm, masseter, tongue, extraocular, and intercostal muscles are most heavily parasitized), and eosinophilia (often extreme — >50% of circulating leukocytes may be eosinophils). Cardiac and neurological involvement (myocarditis, encephalitis) can be fatal in heavy infections. Diagnosis is by serology (anti-Trichinella antibodies), muscle biopsy, or detection of larvae in meat suspected as the source. Treatment with albendazole or mebendazole is most effective during the intestinal phase; steroids are added for severe inflammatory disease.

Chapter 5: Arthropod Parasites and Vectors

Section 5.1: Ticks — Biology, Feeding, and Disease Transmission

Ticks (order Ixodida, class Arachnida) are obligate blood-feeding ectoparasites that rank second only to mosquitoes as vectors of human infectious disease. They are divided into two families: the Ixodidae (hard ticks, with a sclerotized dorsal shield, the scutum) and the Argasidae (soft ticks, without a scutum). Hard ticks take one prolonged blood meal at each life stage (larva, nymph, adult), feeding for days to weeks before detaching and molting or laying eggs. Soft ticks feed rapidly (minutes to hours) and repeatedly throughout their lives.

The feeding biology of hard ticks is elaborate. When a hard tick attaches to a host, it first cuts through the skin with its chelicerae and then inserts the hypostome — a barbed, harpoon-like structure — into the wound. It then secretes a cement cone (composed of cross-linked proteins from the salivary glands) that anchors the tick to the skin with extraordinary tenacity; the cement hardens to form an almost inseparable attachment, which is why removing a hard tick without leaving the mouthparts behind requires careful technique. Tick saliva is pharmacologically complex, containing anticoagulants (to maintain blood flow), vasodilators, anti-platelet agents, and importantly, immunomodulatory compounds (including prostaglandins, cytokine inhibitors, and complement inhibitors) that suppress the host’s inflammatory and immune response at the feeding site. These immunomodulatory compounds create a localized “immunological fog” that not only facilitates undisturbed feeding but also facilitates pathogen transmission — most pathogens transmitted by ticks are injected with saliva and exploit the immunosuppressed microenvironment at the bite site to establish infection.

Ixodes scapularis (the black-legged or deer tick) in northeastern North America transmits Borrelia burgdorferi (Lyme disease), the most commonly reported vector-borne disease in the United States and Canada. B. burgdorferi is a spirochete bacterium that — though technically not a parasite in the classical sense — is transmitted by an arthropod vector and requires understanding within a parasitological framework. The white-tailed deer (Odocoileus virginianus) serves as the primary host for adult I. scapularis (maintaining tick populations) while the white-footed mouse (Peromyscus leucopus) serves as the primary reservoir for B. burgdorferi (maintaining the pathogen in the ecological cycle). Nymphal ticks (which are tiny — approximately 1–2 mm — and easily missed) are responsible for the majority of Lyme disease transmission because they feed in spring and summer when human outdoor activity is highest. Climate change is expanding the geographic range of I. scapularis northward into previously tick-free areas of Canada, widening the risk zone for Lyme disease.

Dermacentor variabilis (the American dog tick) and D. andersoni (the Rocky Mountain wood tick) are Ixodid ticks that transmit Rickettsia rickettsii, the causative agent of Rocky Mountain spotted fever (RMSF) — despite the name, most cases occur in the southeastern and south-central United States. Rickettsia rickettsii (another non-classical parasite but firmly within vector-borne disease ecology) is an obligate intracellular bacterium that infects endothelial cells of blood vessels, causing vasculitis, the petechial rash characteristic of RMSF, and potentially life-threatening systemic vascular damage. Unlike Borrelia, Rickettsia is present in the salivary glands of the tick before feeding and can be transmitted within 2–6 hours of attachment if the tick is already activated — hence prompt removal is important for all tick bites.

Section 5.2: Sarcoptes scabiei — Scabies

Sarcoptes scabiei var. hominis is an obligate parasitic mite (class Arachnida, order Sarcoptiformes) that causes scabies — an intensely pruritic skin infestation affecting approximately 300 million people globally and a leading cause of skin disease in resource-limited settings. The female mite (0.3–0.4 mm long) burrows into the stratum corneum of the skin using its chelicerae and two pairs of front legs armed with cutting spines; it excavates a tortuous burrow 2–3 mm per day, depositing 2–3 eggs daily. The mite does not penetrate below the stratum corneum and feeds on dissolved skin tissue. The burrow is typically found in the thin skin of the interdigital web spaces, wrists, ankles, nipples, and genitalia — but never on the face (in adults). Larvae hatch within 3–4 days, emerge from the burrow, and develop on the skin surface through protonymph, tritonymph, and adult stages.

The intense pruritus of scabies is not caused by the mites themselves but by the host’s delayed-type hypersensitivity response to mite proteins, feces, and eggs. The reaction develops 4–6 weeks after primary infestation (explaining why a person can be heavily infested without symptoms during the early period), but in re-infestation it develops within 1–4 days. The classical presentation is intense nocturnal pruritus (worse at night, possibly because the mites are more active in warm conditions) with an erythematous papular rash; visualization of the burrow (a short wavy line ending in a small papule) with dermoscopy or using ink allows definitive identification.

Norwegian (crusted) scabies is a severe, hyperinfective form that occurs almost exclusively in immunocompromised individuals (HIV/AIDS, HTLV-1 infection, organ transplant recipients, elderly institutionalized patients). Rather than the usual 10–20 mites found in classical scabies, crusted scabies involves thousands to millions of mites living in thick, hyperkeratotic crusts that cover large areas of the body surface. The massive mite burden means that the host is extraordinarily contagious — a single patient with crusted scabies can transmit scabies to entire hospital wards or nursing home units through indirect contact (via shed crusted skin containing viable mites and eggs). Treatment of crusted scabies is much more challenging than classical scabies, requiring repeated courses of topical permethrin and/or oral ivermectin.

Section 5.3: Demodex — Follicle Mites

Demodex folliculorum and D. brevis are commensal or parasitic mites (the distinction depends on host immune status) that inhabit the hair follicles and sebaceous glands of virtually all adult humans. The mites feed on sebum and follicular cells and typically cause no symptoms in immunocompetent individuals. At very high densities — particularly in immunocompromised hosts or in association with inflammatory skin conditions — Demodex may contribute to rosacea, blepharitis (inflammation of the eyelids), and other dermatological conditions. Demodex infestation is used as a model system for studying the spectrum between commensalism and parasitism.

Section 5.4: Myiasis — Tissue Invasion by Fly Larvae

Myiasis is the infestation of living animal tissue by fly larvae (maggots). Several fly species have evolved obligate or facultative myiasis-causing habits. Dermatobia hominis (the human botfly, Central and South America) is a striking example of obligate myiasis: the female captures a blood-feeding arthropod (typically a mosquito or tick) and glues her eggs to its abdomen. When the carrier insect subsequently lands on a warm-blooded host, the body heat causes the botfly eggs to hatch, releasing L1 larvae that penetrate the skin and develop through L2 and L3 stages within a subcutaneous nodule (a warble) over approximately 6–10 weeks. The breathing pore of the nodule is visible at the skin surface, through which the larva periodically extends its posterior spiracles to breathe. The larva eventually exits the nodule to pupate in soil. The treatment is occlusion of the breathing pore (with petroleum jelly, tape, or other substances) to force the larva to emerge, followed by careful manual extraction.

Cochliomyia hominivorax (the New World screwworm fly) is an obligate wound myiasis fly that was eradicated from the United States, Mexico, and Central America through the Sterile Insect Technique (SIT) — one of the most successful pest eradication campaigns in history. Female screwworm flies lay eggs in fresh wounds or natural body orifices of warm-blooded animals; the resulting larvae feed actively on living tissue, causing severe, enlarging wounds. The SIT involved the mass rearing and irradiation of male screwworm flies (rendering them sterile) and their release in enormous numbers; sterile males competed with wild males for females, progressively reducing the breeding population to extinction.

Section 5.5: Lice, Fleas, and Other Ectoparasites

Pediculus humanus exists as two varieties: P. h. capitis (the head louse) and P. h. corporis (the body louse). The body louse is of particular public health importance because it serves as the vector for three major epidemic diseases: epidemic typhus (Rickettsia prowazekii), trench fever (Bartonella quintana), and louse-borne relapsing fever (Borrelia recurrentis). Body lice live in the seams of clothing (unlike head lice, which live on the scalp) and are transmitted through close contact and sharing of clothing. They feed by piercing the skin and sucking blood; they defecate while feeding, and the feces contain infectious rickettsiae that enter the bite wound when scratched. Epidemic typhus has caused millions of deaths in wars and famines throughout history, most notoriously in the First and Second World Wars and the Napoleonic campaigns.

Pulex irritans (the human flea) is a competent vector for plague (Yersinia pestis) and the direct cause of flea-borne typhus (Rickettsia typhi). The transmission of plague by the rat flea (Xenopsylla cheopis) is the classic mechanism of bubonic plague epidemics: Y. pestis forms a blockage in the flea’s proventriculus (a valve in the foregut); when the blocked flea attempts to feed, blood is drawn up and then regurgitated (with bacteria) back into the bite wound. Pulex irritans is a less efficient plague vector than Xenopsylla cheopis but is responsible for maintaining plague in human communities in the absence of dense rat populations.

Chapter 6: Trypanosomatidae — African and American Trypanosomiasis, Leishmaniasis

Section 6.1: Trypanosoma brucei and African Sleeping Sickness

Trypanosoma brucei (order Kinetoplastida, family Trypanosomatidae) causes human African trypanosomiasis (HAT), transmitted exclusively by the bite of Glossina (tsetse fly) species in sub-Saharan Africa. Two subspecies differ in epidemiology and disease course: T. b. gambiense (West and Central Africa) causes a slowly progressive chronic disease; T. b. rhodesiense (East Africa) causes a more acute, rapidly fatal disease. A third subspecies, T. b. brucei, causes animal trypanosomiasis (nagana) in cattle but does not infect humans because of a serum resistance factor (apolipoprotein L-I, ApoL-I) that lyses T. b. brucei but not the human-infective subspecies.

The kinetoplastids have several unique molecular features that distinguish them from other eukaryotes. They are named for the kinetoplast — a network of interlocked circular DNA molecules (maxicircles and minicircles) within the single large mitochondrion that encodes mitochondrial proteins; kinetoplast replication and segregation are extraordinarily complex and are the target of some trypanocidal drugs. Kinetoplastid RNA undergoes extensive RNA editing (insertion and deletion of uridine residues to create functional mRNA) that is without parallel in other organisms. These unique features represent potential drug targets.

T. brucei alternates between two principal life forms: the procyclic trypomastigote in the tsetse fly midgut (which is covered by procyclin, an EP repeat-containing GPI-anchored protein, and derives energy from amino acid catabolism) and the bloodstream trypomastigote in the mammalian host (which is covered by VSG and relies on glycolysis — and lacks a functional oxidative phosphorylation chain, relying instead on a plant-like mitochondrial electron transport chain that is the target of several drugs including pentamidine).

Antigenic variation via VSG is the principal immune evasion strategy of T. brucei and one of the most sophisticated biological mechanisms known. The entire surface of the bloodstream trypomastigote is covered by approximately 10 million copies of a single variant surface glycoprotein (VSG), forming a dense protective coat that sterically blocks complement attack and antibody access to underlying invariant surface proteins. The T. brucei genome contains approximately 1,600 VSG genes, but only one is expressed at a time, from one of approximately 20 expression sites — specialized telomeric loci with unique promoter arrangements. Switching to a new VSG can occur through two mechanisms: transcriptional switching (silencing one expression site and activating another) and gene conversion (copying a different VSG gene into the active expression site, replacing the previously expressed gene by recombination). The switching rate is approximately 10⁻⁶ to 10⁻⁷ per cell per generation — low enough that virtually all parasites at any given time express the same VSG, but sufficient that a small number of parasites expressing different VSGs survive each wave of antibody-mediated killing. The result is the characteristic relapsing parasitemia of sleeping sickness: successive waves of parasitemia, each expressing a new VSG variant, separated by partial clearance by antibody. Because of antigenic variation, a protective vaccine against HAT appears biologically implausible.

Disease progression in T. b. gambiense HAT follows two stages. Stage 1 (hemolymphatic stage): the parasite circulates in blood, lymph, and lymph nodes, causing irregular fever, headache, malaise, lymphadenopathy (particularly in the posterior cervical triangles — Winterbottom’s sign, named for the nineteenth-century British physician who described it), and hepatosplenomegaly. Stage 2 (meningoencephalitic stage): the parasite crosses the blood-brain barrier and invades the CNS, causing the characteristic neurological manifestations: disruption of the sleep-wake cycle (reversal of the normal diurnal sleep pattern — the patient is somnolent during the day and insomniac at night, reflecting disruption of circadian rhythm regulation by the hypothalamus and thalamus), progressive cognitive impairment, behavioral changes, psychiatric symptoms, and ultimately coma and death.

Treatment differs between stages and species. For stage 1 T. b. gambiense: pentamidine (an aromatic diamidine that enters trypanosomes via adenosine transporters and disrupts mitochondrial membrane potential and DNA synthesis) is given parenterally. For stage 2 T. b. gambiense: eflornithine (DFMO, an ornithine decarboxylase inhibitor that blocks polyamine synthesis — polyamines are essential for cell division in T. brucei) is given by intravenous infusion for 14 days; it is not effective against T. b. rhodesiense because that subspecies has higher ornithine decarboxylase turnover. The combination of eflornithine with nifurtimox (NECT — Nifurtimox-Eflornithine Combination Therapy) requires shorter eflornithine infusion duration and has become standard treatment. For T. b. rhodesiense at any stage: suramin (stage 1) and melarsoprol (stage 2). Melarsoprol is an organic arsenical that kills trypanosomes by reacting with trypanothione (a bis-glutathione-spermidine compound unique to kinetoplastids that serves as their principal antioxidant — analogous to glutathione in mammalian cells) and inhibiting trypanothione reductase. Melarsoprol is highly effective but has a 5–10% incidence of fatal encephalopathic reactions (post-treatment reactive encephalopathy, PTRE) — making it one of the most toxic drugs in current medical use. Fexinidazole, a nitroimidazole oral drug, has recently been approved for both stages of T. b. gambiense HAT and represents a major advance in treatment.

Section 6.2: Trypanosoma cruzi and Chagas Disease

Trypanosoma cruzi causes Chagas disease (American trypanosomiasis), affecting approximately 6–7 million people primarily in Latin America and an increasing number of immigrants in North America, Europe, and Australia. Unlike T. brucei, which is transmitted via tsetse fly saliva, T. cruzi is transmitted by triatomine bugs (subfamily Triatominae, family Reduviidae — “kissing bugs”), via their feces. This indirect mechanism (contamination-based rather than inoculation-based transmission) was discovered by the Brazilian physician Carlos Chagas in 1909.

The life cycle of T. cruzi is distinctive. In the triatomine vector (which feeds nocturnally on sleeping humans, preferring the face — giving rise to the name “kissing bug”), bloodstream trypomastigotes taken in with the blood meal differentiate into epimastigotes that replicate in the midgut, then transform into infective metacyclic trypomastigotes in the hindgut. The bug defecates at the feeding site during or after feeding; the trypomastigotes in the feces gain entry through the bite wound (when scratched), the intact mucosa (conjunctiva, lips, nasal mucosa), or mucous membranes. Once in the mammalian host, trypomastigotes enter cells (macrophages and other cell types at the inoculation site, then cardiomyocytes, smooth muscle cells, and neurons throughout the body) by a unique mechanism involving lysosomal recruitment — they are taken up into a parasitophorous vacuole formed by lysosomes fusing with the plasma membrane, and then they lyse this vacuole to escape into the cytoplasm, where they transform into amastigotes and replicate by binary fission. When the host cell is full of amastigotes, they transform back into trypomastigotes, lyse the cell, and are released to infect new cells or enter the bloodstream.

Acute Chagas disease (weeks 0–8) is characterized by the acute inflammatory response to initial infection. At the portal of entry, a local inflammatory swelling called the chagoma develops (in the skin) or Romaña’s sign (unilateral painless periorbital edema, when the conjunctiva is the portal) develops within days. The circulating trypomastigotes trigger fever, malaise, lymphadenopathy, and hepatosplenomegaly. Myocarditis (inflammation of the heart muscle) and meningoencephalitis may occur in severe acute cases, particularly in young children and immunocompromised individuals, and are potentially fatal. Most acute infections resolve with or without treatment, but the parasite persists in tissue amastigote form.

Chronic Chagas disease develops in approximately 30–40% of chronically infected individuals, typically decades after primary infection. The pathological hallmarks are dilated cardiomyopathy (Chagasic cardiomyopathy) and hollow organ disease (megaesophagus, megacolon). The mechanism of cardiomyopathy remains debated but involves both direct parasite-mediated myocyte destruction and autoimmune damage: antiparasite antibodies cross-react with cardiac antigens (particularly with the beta-1 adrenergic receptor and muscle-specific kinase), causing cardiomyocyte dysfunction and death independent of ongoing parasite burden. The result is progressive cardiomegaly, interventricular septal fibrosis, ventricular aneurysm (particularly of the left ventricular apex — a characteristic feature of Chagasic heart disease that helps distinguish it from other causes of dilated cardiomyopathy on echocardiography), arrhythmias (including right bundle branch block — also characteristic), and ultimately heart failure. Megaesophagus and megacolon result from the destruction of the autonomic ganglia of the gut wall (Meissner’s and Auerbach’s plexuses) by invading amastigotes; loss of the enteric nervous system causes dilatation and dysmotility of the esophagus (with dysphagia and regurgitation) and colon (with severe constipation, obstipation, and risk of volvulus).

Treatment with benznidazole or nifurtimox (the only two available drugs) is highly effective if given during the acute phase (>90% parasitological cure rate); efficacy declines in the chronic phase (approximately 20–30% parasitological cure rate in clinical trials) because residual tissue cysts sequestered in cardiomyocytes and smooth muscle cells are difficult to reach and the established structural damage is irreversible. Both drugs are nitroreductase-activated nitroaromatics that generate reactive metabolites toxic to T. cruzi cells; because the human host lacks the relevant nitroreductase enzymes, the drugs are selectively toxic to the parasite.

Section 6.3: Leishmania — A Spectrum of Disease

The genus Leishmania comprises approximately 20 species pathogenic to humans, transmitted by the bite of female sandflies (genus Phlebotomus in the Old World, Lutzomyia in the New World). The clinical spectrum — from self-healing cutaneous ulcers to lethal visceral disease — is among the broadest of any single parasite genus and reflects both parasite species differences and host immune response variations.

In the sandfly, Leishmania exists as elongated, flagellated promastigotes that develop in the fly’s midgut (procyclic promastigotes, which divide rapidly) and differentiate into infective metacyclic promastigotes in the fly’s pharynx and mouthparts. When the fly feeds, metacyclic promastigotes are deposited in the skin with the saliva. In the mammalian host, promastigotes are phagocytosed by dendritic cells and macrophages — cells whose normal function is to kill phagocytosed microorganisms. Leishmania has evolved a suite of mechanisms to subvert this microbicidal machinery. The parasite’s surface is coated with lipophosphoglycan (LPG) and gp63 (leishmanolysin) — molecules that inhibit complement-mediated killing, modulate phagosome maturation (preventing the phagosome from fusing with lysosomes, or surviving lysosomal fusion by resisting acidic pH and lysosomal enzymes), and inhibit the production of reactive oxygen species by the macrophage respiratory burst. Inside the phagolysosome, metacyclic promastigotes transform into amastigotes — oval, non-flagellated (or very short-flagellated) forms approximately 2–5 µm in diameter, with a visible kinetoplast adjacent to the nucleus. Amastigotes replicate by binary fission within the phagolysosome (a uniquely harsh intracellular environment that they are adapted to thrive in) and are released when the host cell lyses, to infect new macrophages.

Cutaneous leishmaniasis (CL) — caused by L. major, L. tropica, and L. aethiopica in the Old World, and L. braziliensis, L. mexicana, and others in the New World — typically presents as a painless papule at the site of the sandfly bite that slowly enlarges and ulcerates over weeks to months, producing the characteristic “volcano crater” ulcer: a round or oval lesion with raised, indurated edges and a clean base, often on an exposed area of skin (face, ears, hands, arms). Most cutaneous lesions heal spontaneously within 3–18 months but may leave disfiguring scars. Treatment (topical or systemic, depending on lesion size, species, and immunological status) includes meglumine antimoniate or sodium stibogluconate (pentavalent antimonials), miltefosine, fluconazole, thermotherapy, or amphotericin B.

Mucocutaneous leishmaniasis (MCL) — caused primarily by L. (Viannia) braziliensis — occurs months to years after the primary cutaneous lesion has healed, when parasites disseminate to the mucous membranes of the nasopharynx, producing a destructive inflammatory process that slowly destroys the nasal septum, soft palate, and pharynx. The resulting disfigurement (with collapse of the nasal septum — the “tapir nose” deformity) is one of the most dramatic examples of parasite-induced tissue destruction. MCL requires systemic treatment and is harder to cure than CL.

Visceral leishmaniasis (VL, kala-azar) — caused by L. donovani in South Asia and East Africa, and L. infantum in the Mediterranean, Middle East, and Latin America — is the most severe form of leishmaniasis and is fatal without treatment. Parasites disseminate from the initial infection site through the bloodstream to infect macrophages throughout the mononuclear phagocyte system — particularly in the spleen, liver, and bone marrow. The clinical presentation after an incubation period of months to years includes persistent fever, massive splenomegaly (the spleen may be palpable in the left iliac fossa), hepatomegaly, progressive weight loss, and pancytopenia (anemia, leukopenia, and thrombocytopenia) from bone marrow infiltration with parasitized macrophages. The skin may become darkened (kala-azar means “black fever” in Hindi/Bengali, referring to this darkening). Without treatment, almost all VL patients die. Successful treatment results in a post-kala-azar dermal leishmaniasis (PKDL) syndrome in some patients — a skin rash caused by residual parasites in dermal macrophages — which is important as a potential transmission reservoir.

Treatment of VL historically used pentavalent antimonials (meglumine antimoniate or sodium stibogluconate — organic salts of antimony that, inside the macrophage, are reduced to trivalent antimony, which inhibits trypanothione reductase and is toxic to amastigotes). Increasing antimonial resistance has driven use of liposomal amphotericin B (L-AmB) as the preferred treatment in many settings — lipid formulation reduces the nephrotoxicity of conventional amphotericin B while maintaining efficacy through preferential uptake by macrophages (the very cells harboring the parasites). Miltefosine (hexadecylphosphocholine) — the first oral drug for VL — was developed as an anticancer drug (it inhibits phosphatidylcholine synthesis and induces apoptosis-like cell death in Leishmania amastigotes) and is now used in South Asia. Combination therapy regimens are increasingly used to prevent resistance emergence.

Chapter 7: Intestinal and Urogenital Flagellates — Giardia and Trichomonas; Cryptosporidium

Section 7.1: Giardia intestinalis — The Adhesive Disc and Malabsorption

Giardia intestinalis (synonyms: G. lamblia, G. duodenalis) is the most commonly diagnosed intestinal protozoan parasite in the world and a leading cause of diarrheal disease in both developed and developing countries. It is classified within the Metamonada (Excavata supergroup), a deeply branching eukaryotic lineage. Giardia is unusual in being a binucleate organism (each trophozoite contains two nuclei, both of which are transcriptionally active and genetically equivalent) and in lacking mitochondria (containing mitosomes — vestigial organelles without respiratory function). These features reflect the ancient evolutionary divergence of this lineage.

Giardia exists in two forms. The trophozoite (10–20 µm long, 5–15 µm wide) is the metabolically active, reproducing form that colonizes the upper small intestine. It is pear-shaped, dorsoventrally flattened, and bears four pairs of flagella. The ventral surface contains the adhesive disc — a rigid concave structure composed of microtubules and microribbons that can generate suction when the flagella beat beneath it, allowing the trophozoite to adhere to the intestinal brush border with considerable tenacity. The cyst (8–12 µm) is the environmentally resistant stage shed in feces. Cysts contain four nuclei (formed by nuclear division without cytokinesis) and pre-formed flagellar structures. Cysts are immediately infective when shed — there is no maturation period required outside the host. The infectious dose is remarkably low — as few as 10–25 cysts can establish infection in humans — which facilitates waterborne outbreaks even when contamination levels are low.

Excystation occurs in the duodenum, triggered by the low pH of gastric contents followed by the neutral pH and bile salts of the small intestine. Each cyst excysts into two trophozoites. Trophozoites multiply by binary fission in the small intestine and may remain in the lumen (causing no symptoms) or attach to the brush border of the jejunum, where they disrupt nutrient absorption. The mechanism of diarrhea in giardiasis is not invasion — trophozoites do not invade the epithelium. Instead, pathogenesis involves disruption of the intestinal brush border by mechanical contact (the adhesive disc damages microvilli), parasite secretion of proteases that cleave brush border proteins, induction of intestinal epithelial cell apoptosis, and disruption of tight junctions (increasing intestinal permeability). The net result is malabsorption — of fat (steatorrhea — foul-smelling, greasy stools), fat-soluble vitamins, lactose (secondary lactase deficiency), and other nutrients. The diarrhea of giardiasis is therefore typically non-bloody and non-inflammatory (distinguishing it from amoebic colitis or bacterial dysentery), and the feces are characteristically described as “greasy” or “foul-smelling” rather than frankly watery.

Giardia cysts are extraordinarily resistant to chlorine at the concentrations used in municipal water treatment, explaining why waterborne giardiasis outbreaks occur in chlorinated municipal supplies when filtration is inadequate. Boiling water, filtration (pore size 1 µm), or UV irradiation are effective. Treatment of symptomatic giardiasis uses metronidazole (a 5-nitroimidazole that generates toxic radical anions inside anaerobic or microaerophilic cells via nitroreductase activation — Giardia, like other anaerobes, has nitroreductases that activate the drug, while host cells, which have aerobic metabolism, are largely protected) or tinidazole (a single-dose alternative with similar mechanism). Nitazoxanide is an alternative with a broader antiparasitic spectrum.

Section 7.2: Trichomonas vaginalis — Iron-Regulated Virulence

Trichomonas vaginalis is a flagellate protozoan (class Parabasalia) that causes trichomoniasis — the most common non-viral sexually transmitted infection globally, with approximately 156 million new cases annually. Unlike Giardia, Trichomonas has no cyst stage — it exists only as a trophozoite (7–32 µm, pear-shaped with 4 anterior flagella and an undulating membrane) and is transmitted directly from person to person during sexual contact. It inhabits the vaginal epithelium, the urethra, and the prostate; it cannot survive outside the human host for more than a few hours under ambient conditions.

Pathogenesis of trichomoniasis is multifactorial and importantly regulated by iron concentration. In the normal vaginal environment, iron concentrations are low (bound to transferrin, lactoferrin, and ferritin). At low iron concentrations, T. vaginalis upregulates expression of cysteine proteases (particularly adhesins and TvCP2, TvCP4) that degrade vaginal epithelial cell proteins, facilitating adherence and invasion of the epithelial surface. At higher iron concentrations (which occur during menstruation, when iron from hemoglobin becomes available), the organism down-regulates these virulence factors — a regulatory strategy that may reflect an adaptation to avoid destroying the host niche. The immune response (cervicitis, vaginitis) to T. vaginalis infection significantly increases susceptibility to HIV acquisition (by recruiting CD4+ T cells and disrupting the mucosal barrier), making trichomoniasis an important HIV co-factor in populations where both are prevalent. Most men with trichomoniasis are asymptomatic, making them a major transmission reservoir. Treatment is with metronidazole or tinidazole; both partners must be treated simultaneously to prevent re-infection.

Section 7.3: Cryptosporidium parvum — Oocyst Biology and Immunocompromised Vulnerability

Cryptosporidium parvum and C. hominis are coccidian parasites (phylum Apicomplexa) that cause cryptosporidiosis — a self-limiting watery diarrheal illness in immunocompetent hosts and a potentially life-threatening, chronic diarrheal disease in immunocompromised individuals (particularly those with CD4 counts below 200 cells/µL, the same threshold for PCP risk). Cryptosporidium occupies a unique intracellular niche: it is intracellular but extracytoplasmic — parasites reside within a vacuole that is surrounded by host cell membrane on the outer surface but does not communicate with the host cell cytoplasm, sitting instead in an invagination of the microvillous border of intestinal epithelial cells. This unique compartmentalization may explain why it is refractory to many drugs that work against other intracellular parasites.

The oocyst is the environmentally resistant infectious stage — a thick-walled, 4–5 µm structure containing four sporozoites. Oocysts are shed in enormous numbers in feces (up to 10⁹ per gram in heavy infections) and are exceptionally resistant to environmental degradation, surviving for months in cold water and resisting the chlorine concentrations used in municipal water treatment. Filtration through slow sand filters or membrane filters with pore size <1 µm effectively removes oocysts; UV irradiation is also effective. The 1993 Milwaukee waterborne outbreak (approximately 403,000 ill) was caused by failure of a municipal water filtration plant, demonstrating the catastrophic potential of Cryptosporidium in municipal water supplies. Nitazoxanide is the only FDA-approved drug with demonstrated efficacy against cryptosporidiosis in immunocompetent patients; in immunocompromised patients, no reliably effective antiparasitic treatment exists, and immune reconstitution (e.g., initiation of antiretroviral therapy in HIV-infected patients) is the most effective intervention.

Chapter 8: Apicomplexa — Malaria, Toxoplasma, and Babesia

Section 8.1: Plasmodium falciparum — The Malaria Parasite

Malaria is the most important parasitic disease of humans by any metric of global health impact. Plasmodium falciparum — responsible for 90–95% of malaria-attributable deaths — kills approximately 600,000–900,000 people annually, primarily children under five in sub-Saharan Africa. Five Plasmodium species infect humans: P. falciparum (most severe), P. vivax (most widespread geographically, causes relapsing malaria), P. malariae (mild, chronic), P. ovale (mild, relapsing), and P. knowlesi (zoonotic, from macaques in Southeast Asia, can cause severe malaria).

The malaria life cycle is orchestrated across two hosts — the Anopheles mosquito (definitive host, site of sexual reproduction) and the human (intermediate host, site of asexual amplification). Sporozoites injected by the feeding mosquito travel through the bloodstream to the liver within 30–60 minutes. They must traverse the liver sinusoidal wall (passing through Kupffer cells by a transcytosis mechanism), contact hepatocytes, and invade them using the apical complex machinery — a collection of secretory organelles (rhoptries, micronemes, dense granules) that discharge sequentially during invasion, first releasing adhesins that bind hepatocyte surface molecules, then discharging a moving junction (formed by the RON proteins from rhoptries and AMA1 from micronemes) through which the sporozoite enters the host cell. Inside the hepatocyte, the parasite develops in a parasitophorous vacuole into a hepatic schizont containing thousands of merozoites — 10,000–30,000 per hepatocyte in P. falciparum. After 5.5–16 days (depending on species), the hepatocyte ruptures, releasing merozoites enclosed in merosomes (parasite-derived membrane packets) that protect them during transit through the liver sinusoids.

Once inside the red cell, the parasite undergoes erythrocytic schizogony: development through ring (early trophozoite), trophozoite, and schizont stages over 48 hours (P. falciparum, P. vivax, P. ovale) or 72 hours (P. malariae), ultimately producing 8–32 new merozoites that are released when the red cell ruptures. During this development, the parasite digests ~80% of the host cell’s hemoglobin in a specialized organelle called the food vacuole (acidic, analogous to a lysosome). Hemoglobin is degraded by a series of proteases (plasmepsins, falcipain, falcilysin) to amino acids that the parasite uses for protein synthesis; however, the porphyrin ring of heme — released as toxic free heme (ferriprotoporphyrin IX) — would be toxic to the parasite if allowed to accumulate. The parasite biomineralizes free heme into an insoluble crystalline structure called hemozoin (malaria pigment) — a unique biological polymer that is non-toxic to the parasite, visible as dark granules in infected cells, and responsible for the dark color of the malaria-infected spleen and liver. Chloroquine acts by accumulating in the food vacuole and binding free heme, preventing hemozoin formation and allowing toxic heme concentrations to build up within the parasite. Chloroquine resistance in P. falciparum is mediated primarily by mutations in PfCRT (Plasmodium falciparum chloroquine resistance transporter), a transmembrane protein in the food vacuole membrane; the K76T mutation in PfCRT allows chloroquine to be exported from the food vacuole, reducing its effective concentration at the site of action.

Severe malaria (WHO definition) includes cerebral malaria (impaired consciousness, coma, seizures), severe anemia (hemoglobin <7 g/dL), acute respiratory distress syndrome, renal failure, metabolic acidosis, hypoglycemia, spontaneous bleeding, and hyperparasitemia (>5% of red cells infected). The defining virulence characteristic of P. falciparum that distinguishes it from other Plasmodium species is cytoadherence — the binding of P. falciparum-infected red blood cells (iRBCs) to endothelial cells in the microvasculature of the brain, placenta, and other organs, causing sequestration of iRBCs in these capillary beds. Cytoadherence is mediated by PfEMP1 (P. falciparum erythrocyte membrane protein 1), a large, variable adhesin protein encoded by a family of approximately 60 var genes; like VSG in T. brucei, only one var gene is expressed at a time, and expression switching generates antigenic variation that allows the parasite to evade the immune response. PfEMP1 is expressed on knob structures — electron-dense protrusions on the surface of iRBCs — that concentrate PfEMP1 at adhesion points. PfEMP1 binds endothelial surface molecules including ICAM-1 (intercellular adhesion molecule 1), CD36, EPCR (endothelial protein C receptor, a particularly relevant receptor in severe malaria), and PECAM-1. Rosetting — the clustering of uninfected red cells around iRBCs, mediated by PfEMP1 binding to uninfected red cell surface molecules — exacerbates microvascular obstruction.

Artemisinin (qinghaosu) — originally isolated from the plant Artemisia annua (sweet wormwood) and used in Chinese traditional medicine for millennia — is the most potent and rapidly acting antimalarial drug discovered. Artemisinins (including the semi-synthetic derivatives artesunate, artemether, and dihydroartemisinin) are sesquiterpene trioxane lactones. Their mechanism of action involves activation by heme iron (Fe²⁺) within the Plasmodium food vacuole: the peroxide bridge in the artemisinin molecule is cleaved by heme iron to generate carbon-centered free radicals that alkylate and damage multiple parasite proteins, including PfATP6 (the parasite’s sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase), the proteasome, and mitochondrial electron transport chain components. Artemisinins act on all blood stages, including early rings — which are not targeted by most other antimalarials — explaining their rapid action. Artemisinin-based combination therapies (ACTs) — artemisinin derivative plus a longer-acting partner drug (lumefantrine, amodiaquine, piperaquine, mefloquine) — are the WHO-recommended first-line treatment for uncomplicated P. falciparum malaria globally. Artemisinin partial resistance (characterized by delayed parasite clearance, operationally defined as a K13 mutation in the parasite plus persistence of parasites beyond day 3 of ACT treatment) has emerged in Southeast Asia and more recently in parts of East Africa, raising serious concern about the future of ACT efficacy.

For P. vivax and P. ovale, which form dormant hypnozoites in the liver that can reactivate to cause relapses months to years after the initial infection, primaquine is required to eliminate the liver stage (radical cure). Primaquine is activated by CYP2D6 and generates reactive oxygen species that are toxic to the mitochondria of liver-stage parasites; it also causes hemolysis in individuals with G6PD deficiency (the most common enzymopathy worldwide, affecting ~400 million people, and maintained at high frequency in malaria-endemic populations because of its protective effect against severe P. falciparum malaria). G6PD screening before primaquine administration is therefore essential.

Section 8.2: Toxoplasma gondii — Congenital Infection and CNS Disease

Toxoplasma gondii is among the most successful parasites on Earth, infecting an estimated one-third of the global human population. This success reflects the parasite’s extraordinary host range (virtually all warm-blooded vertebrates serve as intermediate hosts) and the multiple routes by which it is transmitted.

The complex life cycle requires a felid definitive host for sexual reproduction. When a cat ingests tissue cysts (bradycysts) in prey, bradyzoites excyst and initiate sexual development in the small intestinal epithelium, producing oocysts that are excreted in feces — an infected cat may shed millions of oocysts per day for 1–3 weeks after primary infection. Oocysts sporulate (become infective) in the environment within 1–5 days and remain viable in soil for months to years. Horizontal transmission to intermediate hosts occurs by ingestion of sporulated oocysts (from soil, unwashed vegetables, contaminated water) or by ingestion of tissue cysts in undercooked meat (particularly pork, lamb, and venison). Within intermediate hosts, sporozoites (from oocysts) or bradyzoites (from tissue cysts) transform into rapidly dividing tachyzoites that disseminate throughout the body, infecting virtually any nucleated cell via an active invasion mechanism. Tachyzoites then convert to slow-dividing bradyzoites that form tissue cysts (bradycysts) in brain, muscle, and other tissues, where they can persist for the life of the host.

Congenital toxoplasmosis occurs when a pregnant woman experiences primary T. gondii infection during pregnancy; tachyzoites cross the placenta and infect the fetus. The risk of congenital transmission and the severity of fetal damage both vary with gestational age at the time of primary maternal infection: infection in the first trimester carries the lowest risk of transmission (~10–15%) but the highest risk of severe fetal damage if transmission occurs (abortion, stillbirth, severe neurological impairment); infection in the third trimester has the highest transmission risk (~60–80%) but most infected neonates appear healthy at birth and develop late manifestations (chorioretinitis, learning disabilities) only years later. The fetal immune system is immunologically naïve to T. gondii and cannot mount an effective response; the placenta itself offers immune privilege but is not an absolute barrier. The classic triad of congenital toxoplasmosis is chorioretinitis (inflammation and scarring of the retina and choroid), intracranial calcifications (granulomas around foci of tissue necrosis, visible on CT or skull X-ray), and hydrocephalus (caused by obstruction of the aqueduct of Sylvius by periaqueductal inflammation). Spiramycin (given to the mother to reduce placental transmission) and pyrimethamine-sulfadiazine with folinic acid (given to the infected neonate) are used in treatment.

Reactivation toxoplasmosis in immunocompromised individuals — particularly AIDS patients with CD4 counts below 100 cells/µL — causes cerebral toxoplasmosis (toxoplasmic encephalitis), resulting from reactivation of latent bradycysts in the brain. The lesions appear on MRI as ring-enhancing lesions (often multiple, often at the corticomedullary junction or the basal ganglia) that can mimic CNS lymphoma (a distinction that has important therapeutic implications). Empirical treatment with pyrimethamine-sulfadiazine (which inhibits folate synthesis at two sequential steps — sulfadiazine inhibits dihydropteroate synthetase; pyrimethamine inhibits dihydrofolate reductase) is typically initiated before biopsy; a clinical response within 2 weeks confirms the diagnosis. Clindamycin is the alternative if sulfonamide allergy exists.

Section 8.3: Babesia — Tick-Borne Intraerythrocytic Parasites

Babesia species are apicomplexan parasites transmitted by ticks that infect red blood cells in a manner superficially resembling Plasmodium — they appear as small ring-form trophozoites inside red cells — but differ in several key ways: they lack a hepatic stage, they can infect multiple red cells per host cell, and they divide within the red cell by a budding process (merogony) that can produce characteristic “Maltese cross” (tetrad) forms. B. microti is the primary human pathogen in North America (transmitted by Ixodes scapularis); B. divergens is the primary pathogen in Europe (transmitted by Ixodes ricinus). Clinical babesiosis ranges from asymptomatic (in immunocompetent individuals, particularly in areas of high endemicity where acquired immunity develops) to severe hemolytic anemia, hemoglobinuria, jaundice, renal failure, and death in high-risk groups. Asplenic individuals (from anatomic or functional asplenia) are at dramatically increased risk of severe, rapidly fatal babesiosis because the spleen is the primary site of clearance of infected red cells — analogous to their increased risk of severe malaria. The combination of atovaquone plus azithromycin is standard treatment for mild to moderate babesiosis; severe disease requires exchange transfusion plus quinine-clindamycin.

Chapter 9: Amoebae — Entamoeba and Naegleria

Section 9.1: Entamoeba histolytica — Invasive Amoebiasis

Entamoeba histolytica is the causative agent of invasive amoebiasis — the third leading cause of parasitic disease mortality globally (after malaria and schistosomiasis). A critical complication in clinical parasitology is that E. histolytica is morphologically identical to the non-pathogenic Entamoeba dispar, which colonizes the colon of a far greater number of individuals than E. histolytica without causing disease. The WHO/PAHO estimate suggests that while approximately 500 million individuals harbor Entamoeba in their colon, only approximately 50 million have invasive disease annually (primarily from E. histolytica). Distinguishing the two requires antigen detection or PCR, not microscopy.

The life cycle of E. histolytica is direct (no intermediate host). Cysts are shed in feces, are immediately infective, and survive in the environment for weeks to months. Transmission is fecal-oral — through contaminated water, food, or hands. Ingested cysts excyst in the small intestine, releasing trophozoites (10–60 µm, actively motile by pseudopod extension) that colonize the colon, where they may remain in the lumen as commensals or invade the mucosa. The molecular basis of invasiveness involves several key parasite molecules: cysteine proteases (particularly amoepain/EhCP1, EhCP2, EhCP5) that degrade the extracellular matrix (collagen, laminin, fibronectin) and cleave complement components and IgA to evade immune defenses; amoebapore (a pore-forming toxin similar to perforin) that lyses host cells on contact; and a Gal/GalNAc lectin that mediates adherence to colonic mucus and epithelial cells. Tissue invasion produces the characteristic flask-shaped ulcer — a mucosal defect with a narrow neck opening into a broader undermined base — visible on colonoscopy. These ulcers produce bloody mucoid diarrhea (amoebic dysentery), and if they perforate, fulminant amoebic colitis and peritonitis can occur.

Amoebic liver abscess (ALA) occurs in approximately 1–3% of individuals with intestinal amoebiasis: trophozoites penetrate the intestinal mucosa, enter the portal blood, and travel to the liver, where they destroy hepatocytes (by contact killing and secretion of cytotoxic molecules), producing a “anchovy paste” abscess — a cavity filled with necrotic hepatocytes, destroyed white cells, and parasites, liquefied to a chocolate-brown odorless material. The typical presentation is fever, right upper quadrant pain, and hepatomegaly; ultrasound shows a hypoechoic lesion, usually in the right lobe. Amoebic abscess must be distinguished from pyogenic (bacterial) liver abscess, which has important treatment differences. Metronidazole (or tinidazole) is the treatment for invasive amoebiasis (including liver abscess), targeting the tissue trophozoites; it must be followed by a luminal amoebicide (paromomycin or diloxanide furoate) to eliminate the cyst-forming trophozoites in the gut lumen that would otherwise persist and cause recurrence.

Section 9.2: Naegleria fowleri — Primary Amoebic Meningoencephalitis

Naegleria fowleri is a free-living thermophilic amoeba found in warm freshwater (lakes, rivers, hot springs, inadequately maintained swimming pools, warm tap water in hot climates) that causes primary amoebic meningoencephalitis (PAM) — one of the most rapidly fatal infections known, with a mortality rate exceeding 97%. The number of cases globally is small (approximately 300 known cases in the United States between 1962 and 2018), but the near-universal fatality and the dramatic clinical course make it disproportionately important.

Infection occurs when water containing N. fowleri trophozoites enters the nasal cavity (typically during swimming, diving, or nasal irrigation). Trophozoites penetrate the olfactory mucosa and migrate along the olfactory nerve fibers through the cribriform plate into the olfactory bulbs and then throughout the brain — a uniquely direct route to the CNS that bypasses the blood-brain barrier entirely. The amoeba feeds on brain tissue (its name, fowleri, and the species name histolytica for Entamoeba both reflect tissue lysis), destroying neurons and glial cells by direct contact killing (via a sucker-like structure called the amoebostome) and secretion of phospholipases, proteases, and pore-forming molecules. The resulting inflammation — a hemorrhagic meningoencephalitis with rapid edema and herniation — kills within 3–7 days of symptom onset.

Symptoms begin 1–9 days after exposure with headache, fever, and stiff neck (mimicking bacterial meningitis), rapidly progressing to altered taste and smell (reflecting olfactory bulb destruction), hallucinations, behavioral change, seizures, and coma. Cerebrospinal fluid (CSF) examination shows increased pressure, neutrophilic pleocytosis (elevated white cells, predominantly neutrophils), elevated protein, low glucose — an inflammatory CSF picture indistinguishable from bacterial meningitis — but Gram stain and bacterial cultures are negative. Motile amoebae may be detected in wet-mount CSF preparations. Treatment with miltefosine (in combination with amphotericin B, azithromycin, and rifampin) has been associated with the handful of reported survivors; the extreme rarity of survival means that no controlled treatment data exist.

Chapter 10: One Health — Zoonotic Ecology, Environmental Persistence, and Climate Change

Section 10.1: One Health Framework in Parasitology

The One Health framework articulates a truth that parasitologists have understood since the discipline’s inception: the health of humans, domestic animals, wildlife, and their shared ecosystem are inextricably linked. More than 60% of emerging and re-emerging infectious diseases are zoonoses — pathogens originating in animal reservoirs that spill over into human populations. Among parasites specifically, the proportion is even higher: Toxoplasma, Echinococcus, Leishmania, Trypanosoma, Babesia, Toxocara, Trichinella, Cryptosporidium — all are zoonotic or have major zoonotic components. Understanding the One Health perspective requires understanding the ecological systems within which transmission cycles are maintained, and recognizing that perturbations of those systems — through land use change, climate change, urbanization, and agricultural intensification — alter transmission dynamics in ways that affect all components simultaneously.

The transmission dynamics of zoonotic parasites are governed by the concept of the basic reproduction number (R₀) applied to complex multi-host systems. For zoonotic diseases, the effective R₀ in the human host population depends on the spillover rate from the reservoir, the probability of human-to-human transmission (low for most zoonoses), and the duration of the human infectious period. Reservoirs can be managed — reducing the infection prevalence in the reservoir host (through vaccination, culling, or treating) reduces the spillover rate to humans. The success of this approach is demonstrated by programs targeting rabies in fox and raccoon populations through oral vaccination.

Section 10.2: Environmental Persistence of Parasite Transmission Stages

Many parasites persist in the environment for extended periods in transmission stages that must survive until they reach a new host. Understanding this persistence is critical for designing sanitation and control interventions. Ascaris eggs are among the most environmentally resistant parasite eggs: their outer surface is coated with a lipid layer and an ascaroside outer layer that makes them impervious to most chemical disinfectants, resistant to desiccation, and capable of surviving in soil for years. This extraordinary environmental stability explains why ascariasis persists even in communities with improved sanitation, as long as soil from previous heavy contamination remains infectious. Schistosome cercariae, by contrast, are fragile free-swimming organisms that survive for only 8–24 hours after release from the snail, underscoring the importance of snail control (with molluscicides) and reduction of water contact as control strategies.

Giardia and Cryptosporidium oocysts represent a particularly important public health concern because of their resistance to chlorination at concentrations used in municipal water treatment. This resistance is the reason that water treatment guidelines for these organisms emphasize filtration and UV treatment rather than chemical disinfection, and why the failure of filtration at the Milwaukee water treatment plant in 1993 resulted in the largest documented waterborne disease outbreak in US history. Environmental monitoring of water supplies for Giardia cysts and Cryptosporidium oocysts using filtration-IFA (immunofluorescence antibody) methods is now standard practice in many jurisdictions.

Soil-transmitted helminth eggs and larvae survive in tropical soils with moderate moisture and warm temperatures — conditions that also characterize the environments of highest human poverty and poorest sanitation. The “warm, moist, and economically disadvantaged” triangle that defines STH endemicity also describes the environmental conditions ideal for egg and larval survival, perpetuating a cycle of repeated infection that is broken only by the combination of treatment, sanitation improvement, and behavioral change.

Section 10.3: Climate Change and Shifting Vector Ranges

Climate change is altering the distribution and transmission intensity of vector-borne and environmentally transmitted parasites in multiple, interacting ways. Temperature increases directly affect arthropod vector biology: the extrinsic incubation period (EIP) of Plasmodium within the Anopheles mosquito — the time required for sporozoite development after the mosquito takes an infectious blood meal — is temperature dependent, shortening as temperature rises. At temperatures below approximately 16°C, P. falciparum cannot complete development in the mosquito; as warming increases the proportion of the year when temperatures exceed this threshold in highland regions of Africa and Latin America, previously malaria-free highland populations (which have no acquired immunity) are exposed to malaria for the first time. Range expansion of Aedes albopictus (the tiger mosquito, vector of dengue, chikungunya, and Zika viruses) into previously temperate regions of Europe and North America is already well documented and is driven primarily by milder winters. Ixodes scapularis (the Lyme disease tick) is expanding its range northward in Canada at approximately 46 km per year, driven by milder winters that allow tick survival and deer (host) range expansion.

Changes in precipitation affect the availability of freshwater habitats for intermediate hosts. Increased frequency of flooding events may temporarily increase snail (Lymnaea for Fasciola, Biomphalaria for Schistosoma mansoni) habitat availability; conversely, drought may concentrate cercariae in shrinking water bodies, potentially increasing transmission intensity when hosts contact water. Warming of freshwater bodies increases snail reproduction rates and may extend the transmission season for schistosomiasis and fasciolosis.

Deforestation and land use change are among the most powerful drivers of zoonotic parasite emergence. Clearing forest for agriculture brings humans and domestic animals into contact with wildlife reservoirs of parasites they have not previously encountered, while simultaneously altering the ecological community (host diversity) in ways that affect parasite transmission dynamics. The dilution effect hypothesis proposes that high host diversity reduces transmission of many vector-borne parasites by increasing the proportion of vector blood meals taken on non-competent reservoir hosts — deforestation reduces biodiversity, potentially increasing per-capita transmission risk.

Section 10.4: Diagnosis, Treatment Strategy, and Drug Resistance

Diagnosis of parasitic infections has been transformed by molecular methods. Traditional microscopy (examining stained fecal smears, blood films, or tissue sections) remains essential in resource-limited settings and provides morphological information irreplaceable for species identification. Concentration techniques (formalin-ethyl acetate sedimentation for intestinal parasites; thick and thin blood films for malaria) improve sensitivity. Antigen detection (Rapid Diagnostic Tests, RDTs) has become the standard diagnostic tool for malaria in most endemic countries — RDTs detect P. falciparum HRP2 antigen or pan-malaria pLDH with high sensitivity and can be performed by community health workers without laboratory infrastructure. Serology (antibody detection) is valuable for diagnosing tissue parasites (toxoplasmosis, toxocariasis, echinococcosis, trichinellosis) where parasites are not accessible for direct detection. PCR and real-time PCR provide species-level identification and quantification for organisms too morphologically similar to distinguish microscopically (E. histolytica vs. E. dispar; Plasmodium species; Leishmania species).

Drug resistance is an escalating threat to parasitic disease control. The spread of artemisinin-partial resistance in P. falciparum malaria across Southeast Asia (and its emergence in East Africa), driven by mutations in the K13 propeller domain, threatens the efficacy of ACTs — the last widely effective class of antimalarials. Ivermectin resistance in gastrointestinal nematodes of sheep and cattle (driven by intensive use in veterinary contexts) provides a sobering preview of what could occur in human populations under sustained mass drug administration pressure. Antimonial resistance in Leishmania donovani on the Indian subcontinent reached extremely high levels (>65% treatment failure in Bihar, India) and forced the adoption of liposomal amphotericin B as the standard of care. The principles of resistance management — using combination therapies, rotating drugs, targeting treatment to truly infected individuals rather than blanket treatment of uncertain populations, and supporting drug discovery pipelines — apply across all these parasite-drug systems.

Section 10.5: Parasite Immune Evasion — A Synthesis

The interface between parasite and host immune system is the central battlefield of parasitology. Evolution has generated an astonishing diversity of immune evasion strategies, reflecting the different immune environments faced by different parasites and the different host tissues in which they reside.

Intracellular concealment — residing within host cells where circulating antibodies cannot reach — is used by Leishmania amastigotes (within macrophages), T. cruzi amastigotes (within cardiomyocytes), Toxoplasma tachyzoites and bradyzoites (within almost any nucleated cell), and Plasmodium intraerythrocytic stages. Each has evolved specific mechanisms to survive within cells that would normally kill phagocytosed microorganisms: Leishmania prevents lysosomal acidification and inhibits the respiratory burst; T. cruzi lyses the parasitophorous vacuole to escape into the cytosol; Toxoplasma prevents lysosomal fusion by secreting ROP proteins that block phosphatidylinositol 3-phosphate accumulation on the vacuole membrane; Plasmodium constructs a non-fusogenic PVM by excluding standard lysosomal targeting signals.

Antigenic variation — systematically altering the molecular identity of surface antigens to stay one step ahead of the adaptive immune response — is used by T. brucei (VSG switching), P. falciparum (var gene switching to express different PfEMP1 variants), and Giardia (VSP — variant-specific surface protein — switching). These systems vary in molecular mechanism (transcriptional switching, gene conversion, epigenetic silencing) but achieve the same result: the immunological targeting of one surface antigen repertoire is evaded by switching to another.

Active immunosuppression — suppressing the host immune response through parasite-derived immunomodulatory compounds — is pervasive. Adult schistosomes release molecules that induce regulatory T cells (Tregs) and IL-10-producing cells, damping the granulomatous response (a two-edged sword, as noted in Chapter 2). Filarial worms produce molecules (including ES-62, a phosphorylcholine-containing glycoprotein) that actively modulate mast cell and B cell responses. T. cruzi trans-sialidase cleaves sialic acid from host cells and re-deposits it on the parasite surface, providing molecular camouflage. Toxoplasma injects effector proteins (ROPs, GRAs) directly into the host cell nucleus to manipulate host gene expression, including downregulation of MHC Class II presentation.

The understanding of these immune evasion mechanisms has two types of practical value. First, it identifies drug targets: molecules essential for the parasite’s survival within the host (trypanothione reductase, hemozoin formation, PfCRT, Leishmania CRK3) are potential targets for new drugs. Second, it informs vaccine design: the ideal vaccine antigen is an invariant molecule essential for host-cell invasion (AMA1, PfRH5, PfEMP2) that cannot be varied or shed without compromising the parasite’s fitness — though the selection pressure a successful vaccine would impose means that rare variants in the targeted molecule will be strongly selected, a challenge that informs the multi-antigen, multi-stage vaccine strategies currently in advanced clinical trials (R21/Matrix-M malaria vaccine).

These notes cover the parasitology curriculum of BIOL 414 (Winter 2026, University of Waterloo) as taught by Dr. Marcel Pinheiro and Dr. Okey Igboeli. Primary references: Roberts & Janovy, Foundations of Parasitology (9th ed.); WHO Neglected Tropical Disease fact sheets; CDC DPDx (cdc.gov/dpdx); Griffin et al., Parasitic Diseases (8th ed., Parasites Without Borders, 2025).

Chapter 11: Fungi and Microsporidia as Parasites

Section 11.1: Pneumocystis jirovecii

Pneumocystis jirovecii occupies a unique position in the history of medicine and in the classification of parasitology. Originally classified as a protozoan on the basis of its morphology and its susceptibility to antiprotozoal drugs (particularly trimethoprim-sulfamethoxazole), molecular phylogenetics definitively established it as a fungus in the 1980s — yet its biology remains profoundly different from typical fungi. It lacks ergosterol in its cell membrane (rendering standard antifungal drugs like azoles and polyenes ineffective), cannot be cultured on standard fungal media, and is an obligate pulmonary parasite with no known environmental reservoir outside infected mammalian lungs.

P. jirovecii is essentially a ubiquitous organism: seroepidemiological studies show that most immunocompetent humans acquire Pneumocystis exposure in early childhood (with seropositivity approaching 80% by age 4 in many populations), and pulmonary colonization is detectable by PCR in a significant proportion of healthy adults. In immunocompetent individuals, this colonization is entirely asymptomatic and self-limited — controlled by alveolar macrophages and T-cell-mediated immunity. In individuals with severe deficiency of CD4+ T cells (the critical effector population), Pneumocystis proliferates to fill the alveolar spaces with cysts and trophozoites, causing Pneumocystis pneumonia (PCP) — a progressive pneumonitis with dyspnea on exertion, dry non-productive cough, fever, and hypoxia, with bilateral interstitial infiltrates (a “ground-glass” pattern) on chest CT.

The treatment of PCP is trimethoprim-sulfamethoxazole (TMP-SMX) — which inhibits folate synthesis at two sequential steps (sulfamethoxazole blocks dihydropteroate synthase; trimethoprim blocks dihydrofolate reductase), exploiting the fact that mammals do not synthesize folate de novo and are not directly affected by these inhibitors. In immunocompromised patients who are intolerant of TMP-SMX, alternative regimens include pentamidine isethionate (intravenous), atovaquone, or clindamycin-primaquine. Corticosteroids (prednisone or methylprednisolone) are added for moderate to severe PCP to reduce the inflammatory response in the alveoli, which paradoxically worsens gas exchange as the immune system responds. Prophylaxis with daily low-dose TMP-SMX in HIV-infected patients with CD4 counts below 200 cells/µL is one of the most effective preventive interventions in infectious disease medicine.

Section 11.2: Microsporidia

Microsporidia are a large phylum (approximately 1,500 described species) of obligate intracellular parasites now classified within the kingdom Fungi, based on molecular phylogenetics. They are remarkable for their extreme evolutionary reductionism: in adapting to obligate intracellular parasitism, microsporidian genomes have been drastically reduced (to as small as 2.3 Mb in Encephalitozoon intestinalis — the smallest known eukaryotic genome), with the loss of mitochondria (replaced by mitosomes), flagella, peroxisomes, and most metabolic pathways, leaving organisms entirely dependent on the host cell for ATP and many biosynthetic precursors.

The microsporidian spore is the environmentally resistant infectious stage. It is distinguished by the presence of a unique organelle — the polar filament (polar tube) — a tightly coiled tube of protein (ranging from 50 to 500 µm uncoiled, depending on species) that is spring-loaded within the spore under osmotic pressure. When a spore contacts a host cell and is triggered by appropriate stimuli (acidic pH, certain ions), the polar filament is discharged with explosive force at approximately 300 mm/second, penetrating the host cell membrane and injecting the sporoplasm (the infectious content of the spore) directly into the host cell cytoplasm — bypassing endosomal pathways entirely. This remarkable injection mechanism is unique to microsporidia and is of both biological interest and potential biotechnological relevance.

Human microsporidiosis — caused principally by Enterocytozoon bieneusi (the most common microsporidian in humans, inhabiting intestinal epithelium) and Encephalitozoon intestinalis — is primarily an opportunistic infection of immunocompromised individuals. The clinical presentation is watery, non-bloody diarrhea with malabsorption; in AIDS patients before antiretroviral therapy, microsporidiosis was a major cause of chronic wasting diarrhea. Encephalitozoon species cause disseminated disease (kidneys, liver, eyes, brain) in severely immunocompromised hosts. Treatment with albendazole (which targets microsporidian beta-tubulin — despite microsporidia being fungi, their tubulin is highly divergent and sensitive to albendazole) is effective for Encephalitozoon; E. bieneusi is largely refractory to albendazole and is partially responsive to fumagillin (an antibiotic that inhibits methionine aminopeptidase-2). Immune reconstitution remains the most effective intervention.

Chapter 12: Comprehensive Immune Evasion, Coevolution, and Parasite Speciation

Section 12.1: Coevolution at the Host-Parasite Interface

The concept of coevolution — reciprocal evolutionary change in interacting species driven by the selective pressures each imposes on the other — is most vividly illustrated by host-parasite relationships. The Red Queen hypothesis (named after Lewis Carroll’s Red Queen, who must keep running to stay in place) proposes that hosts and parasites are locked in a perpetual evolutionary arms race: as hosts evolve immune recognition of parasite antigens, parasites evolve to evade that recognition; as parasites evolve new pathogenic mechanisms, hosts evolve resistance. The result is continuous evolutionary change without either party achieving a permanent advantage.

Evidence for coevolution is widespread. The extraordinarily high polymorphism of HLA (MHC) genes in human populations — with hundreds of alleles at some loci — is thought to reflect selection by parasites and pathogens: rare HLA alleles are advantageous because they can recognize antigens that common alleles fail to present, and pathogens that have evolved to evade common HLA alleles cannot evade rare ones. This frequency-dependent selection maintains diversity. The global distribution of HLA alleles shows geographic correlations with the historical burden of different infectious diseases. The sickle cell allele (HbS) at the beta-globin locus is the most cited example of a single genetic polymorphism maintained by balancing selection from malaria: HbS heterozygotes are protected against severe P. falciparum malaria (because sickled cells are cleared by the spleen before the parasite can complete its intraerythrocytic cycle) but HbS homozygotes suffer sickle-cell disease — a classic demonstration of overdominance (heterozygote advantage) maintaining a deleterious allele at high frequency in malaria-endemic populations.

Section 12.2: Encounter and Compatibility Filters

The host range of a parasite is determined by two sequential filters. The encounter filter governs whether a parasite ever comes into contact with a potential host: this is determined by geographic overlap, the behaviors of both host and parasite (or vector), and the availability of intermediate hosts or vectors. Many potential host-parasite associations never occur simply because the species involved have non-overlapping geographic ranges — the contact barrier has not been breached. Anthropogenic factors (international travel, wildlife trade, agricultural expansion, climate-driven range shifts) are increasingly allowing parasites to encounter novel hosts beyond their historical range.

The compatibility filter governs whether, having contacted the potential host, the parasite can successfully invade, develop, evade immunity, acquire nutrients, and reproduce. Compatibility is determined by molecular complementarity between parasite invasion ligands and host cell surface receptors (e.g., Plasmodium knowlesi invasion of human red cells requires the Duffy antigen, which is absent in most sub-Saharan Africans — explaining why P. knowlesi is primarily a zoonosis in Southeast Asian populations with Duffy-positive red cells), host immune competence, metabolic availability of required nutrients, and temperature/pH compatibility. Species that fail at the compatibility filter are “accidental dead-end hosts” — they can be infected but the parasite cannot complete its life cycle, as in human toxocariasis and human Baylisascaris procyonis infection.

Section 12.3: Distribution and Aggregation of Parasites

A fundamental empirical observation in parasitology is that parasites are aggregated (overdispersed) in their host populations — the distribution of parasites among hosts is not random (Poisson) but follows a negative binomial distribution, in which most hosts harbor few or no parasites while a small minority of hosts harbor disproportionately large parasite burdens. This aggregation has profound consequences for transmission dynamics, morbidity, and control.

The causes of parasite aggregation include heterogeneity in host exposure (some individuals are exposed more often due to behavior, occupation, or location), heterogeneity in host susceptibility (genetic variation in immune response genes, nutritional status), and the fact that parasite burdens once established are self-reinforcing (heavily infected individuals have impaired immune responses that facilitate further parasite acquisition). From an epidemiological standpoint, the aggregated distribution means that a large proportion of transmission is contributed by the small proportion of heavily infected individuals — implying that targeted treatment of high-intensity infections (rather than universal treatment of all infected individuals) can be highly efficient. This is the biological justification for targeted mass drug administration to school-age children in STH and schistosomiasis control programs.

Section 12.4: Speciation of Parasites and the Comparative Method

The evolutionary history of parasites is inseparable from the evolutionary history of their hosts — a principle that has led to the disciplines of cophylogenetics (comparative analysis of host and parasite phylogenies) and host-parasite cospeciation studies. If a parasite lineage has been associated with a host lineage for a long time, we expect the parasite phylogeny to mirror the host phylogeny (concordant phylogenies), reflecting simultaneous speciation events as the host speciates (cospeciation). Deviations from this pattern — host switches, duplications, missing parasite lineages — indicate events of host switching, host range expansion, and extinction.

The primate lice (Pediculus and Pthirus) provide a famous example: the phylogeny of primate lice is broadly concordant with primate phylogeny, but the position of human pubic lice (Pthirus pubis) — more closely related to gorilla lice (Pthirus gorillae) than to human head and body lice (Pediculus) — implies an ancient cross-species transmission event from gorillas (or a gorilla ancestor) to the human lineage, possibly through shared sleeping sites approximately 3–4 million years ago. Parasite phylogenetics thus provides an independent line of evidence for host evolutionary history.